EPIS® Právní systém | Plné znění

XXXXXXXX XXXXXX (XX) 2019/831

xx dne 22. května 2019,

xxxxxx se xxxx xxxxxxx II, III x X xxxxxxxx Evropského xxxxxxxxxx x Xxxx (XX) x. 1223/2009 x xxxxxxxxxxxx přípravcích

(Xxxx x xxxxxxxx xxx XXX)

XXXXXXXX XXXXXX,

x xxxxxxx xx Xxxxxxx x xxxxxxxxx Xxxxxxxx xxxx,

x xxxxxxx xx nařízení Xxxxxxxxxx xxxxxxxxxx a Rady (ES) x. 1223/2009 xx xxx 30. xxxxxxxxx 2009 x xxxxxxxxxxxx xxxxxxxxxxx (1), x xxxxxxx xx xx. 15 xxxx. 1, xx. 15 xxxx. 2 xxxxxx pododstavec x xx. 31 xxxx. 1 xxxxxxxxx nařízení,

xxxxxxxx x xxxxx xxxxxxx:

(1)

Xxxxxxxx Evropského xxxxxxxxxx a Rady (XX) x. 1272/2008 (2) stanoví xxxxxxxxxxxxxx xxxxxxxxxxx xxxxx xxxx xxxxx xxxxxxxxxxxxxx, mutagenních xxxx xxxxxxxxx xxx xxxxxxxxxx (XXX) xx xxxxxxx xxxxxxxxx xxxxxxxxx Xxxxxx xxx xxxxxxxxxx xxxxx Xxxxxxxx xxxxxxxx xxx chemické látky. Xxxxx jsou xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 1 X, xxxxx XXX xxxxxxxxx 1X xxxx xxxxx XXX xxxxxxxxx 2 v závislosti xx úrovni xxxxxx x xxxxxx vlastnostech XXX.

(2)

Xxxxxx 15 xxxxxxxx (XX) x. 1223/2009 zakazuje používat x xxxxxxxxxxxx přípravcích látky xxxxxxxxxxxxx xxxxx xxxxx 3 xxxxxxx VI xxxxxxxx (XX) x. 1272/2008 (xxxxx XXX) xxxx xxxxx XXX kategorie 1 X, xxxxxxxxx 1X xxxx kategorie 2. Xxxxx CMR xxxx xxxx xxx v kosmetických xxxxxxxxxxx použita, pokud xxxx xxxxxxx xxxxxxxx xxxxxxxxx x xx. 15 xxxx. 1 xxxxx větě xxxx x xx. 15 odst. 2 druhém xxxxxxxxxxx xxxxxxxx (XX) x. 1223/2009. Tímto xxxxxxxxx xx xxxxxxx xxxxxxxx (XX) x. 1223/2009. Xxxxxxxx xxxxx Xxxx, včetně xxxxxx 15 nařízení (XX) x. 1223/2009, xx xxxxxxxx xxxxx Soudní xxxx Xxxxxxxx xxxx.

(3)

X xxxxx xxxxxxxxxx xxxxxxxxx xxxxxx látek XXX x xxxxx xxxxxxxxx xxxx, zajištění právní xxxxxxx xxxxxxx pro xxxxxxxxxxx xxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxx, xxxxx x xxxxxxxxx xxxxxx xxxxxx xxxxxxx lidského zdraví xx xxxxxxx xxxxx XXX xxxx být xxxxxxxx na xxxxxx xxxxxxxxxx xxxxx x xxxxxxx XX nařízení (XX) x. 1223/2009 a případně vyňaty xx seznamů xxxxx xxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxxxx xxxxx x xxxxxxxxx XXX a V uvedeného xxxxxxxx. Xxxxx jsou xxxxxxx xxxxxxxx stanovené v čl. 15 xxxx. 1 xxxxx xxxx xxxx x xx. 15 xxxx. 2 xxxxxx xxxxxxxxxxx nařízení (XX) č. 1223/2009, seznamy xxxxx xxxxxxxxxxxxx omezení xxxx xxxxxxxxxx xxxxx x xxxxxxxxx XXX x X xxxxxxxxx xxxxxxxx xx xxxx xxx odpovídajícím xxxxxxxx xxxxxxx.

(4)	Xxxx nařízení se xxxxxxxx xx xxxxx, xxxxx byly xxxxx xxxxxxxx (XX) x. 1272/2008 xxxxxxxxxxxxx jako xxxxx XXX xx dni 1. xxxxxxxx 2018, xxx se xxxxx xxxxxxxxxxx xxxxxxxx Xxxxxx (XX) 2017/776 (3).

(5)

Xxxxx xxx x xxxxxx xxxxx XXX, xxx xxx xxxx xxxxxxxxxx xxxxxx x xxxxxxxxx použití v kosmetických xxxxxxxxxxx, xxxxxx xxxxxxxxx, xx xxxx splněny xxxxxxx xxxxxxxx xxxxxxxxxx x xx. 15 odst. 1 xxxxx xxxx xxxx x xx. 15 xxxx. 2 druhém xxxxxxxxxxx xxxxxxxx (XX) x. 1223/2009. Xx se xxxx xxxxx Xxxxxxxxxx-15, Chloroacetamide, xxxxxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx xxxxxxxx perborité a perboritanů xxxxxxx.

(6)

Xxxxx methenamin-3-chlorallylchlorid, jejíž xxxxx podle Xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxx xxxxxx (XXXX) zní Xxxxxxxxxx-15, xx x xxxxxxxx xxxx xxxxxxx x xxxxxxx 31 xxxxxxx X xxxxxxxx (ES) x. 1223/2009 xxxx xxxxx xxxxxxxx x xxxxxxxxxxx do 0,2 % v přípravku xxxxxxxxxxx x xxxxxxx. Xxxxx Quaternium-15 xx xxxx cis- x xxxxx-xxxxxxx, xxxxx xxx-xxxxxx xxx xxxxxxxxx Xxxxxx (ES) č. 790/2009 (4) xxxxxxxxxxxx xxxx látka XXX xxxxxxxxx 2. Xxxx klasifikace xx xxxxx xxxxxxxxxxx xxx 1. xxxxxxxx 2010. V souladu s čl. 15 xxxx. 1 xxxxxx xxxxx xxxxxxxx (XX) x. 1223/2009 xxxx být xxxxx xxxxxxxxxxxxx jako kategorie 2 xxxxxxx v kosmetických xxxxxxxxxxx, xxxx-xx xxxxxxxxxx Xxxxxxxx xxxxxxx xxx xxxxxxxxxx xxxxxxxxxxxx (dále xxx „XXXX“) a shledána xxxx bezpečná pro xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx. Xx xxxxx 13. x 14. xxxxxxxx 2011 vydal XXXX xxxxxxx xxxxxxxxxx xxxxxxxx xx látky Quaternium-15 (xxx-xxxxxx) (5), xx xxxxxx xxxxxx k závěru, xx xx základě xxxxxxxxxx xxxxx xxxxx xxxxxxxx xxxxxxxxxx xxxxxxx látky Xxxxxxxxxx-15 x xxxxxxxxxxxx přípravcích. X xxxxxxx na xxxxxxxxxxx xxx-xxxxxxx xxxxxxxxxx x xxxxx Xxxxxxxxxx-15 jako xxxxx XXX xxxxxxxxx 2 x xx xxxxxxxxxx XXXX xx xxxx xxx xxxxx Quaternium-15 xxxxxx xx xxxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxxxx v kosmetických xxxxxxxxxxx x xxxxxxx X xxxxxxxx (XX) č. 1223/2009 a doplněna xx seznam xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx II xxxxxxxxx xxxxxxxx.

(7)

Xxxxx 2-xxxxxxxxxxxxx, xxxxx xxxxx xxxxx XXXX xxx Chloroacetamide, xx x xxxxxxxx xxxx xxxxxxx x xxxxxxx 41 xxxxxxx X xxxxxxxx (ES) č. 1223/2009 xxxx xxxxx xxxxxxxx x xxxxxxxxxxx xx 0,3 % x xxxxxxxxx připraveném x xxxxxxx. Xxxxx Xxxxxxxxxxxxxxx xxxx xxxxx xxxxxxxx (XX) x. 1272/2008 xxxxxxxxxxxxx jako xxxxx XXX kategorie 2. Xxxx klasifikace xx xxxxx xxxxxxxxxxx xxxx 1. xxxxxxxxx 2010, xxx xx xxxxx, xxx xx xxx xxxxx xxxxx xxxxxxxxxx xxxxxxxxxx hlav XX, XXX x XX nařízení (XX) č. 1272/2008. X xxxxxxx x xx. 15 odst. 1 xxxxxx xxxxx xxxxxxxx (XX) x. 1223/2009 xxxx xxx xxxxx xxxxxxxxxxxxx xxxx xxxxxxxxx 2 xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx, xxxx-xx xxxxxxxxxx XXXX x xxxxxxxx xxxx xxxxxxxx xxx xxxxxxx v takových xxxxxxxxxxx. Xxx 22. března 2011 xxxxx XXXX vědecké xxxxxxxxxx xxxxxxxx xx xxxxx Xxxxxxxxxxxxxxx (6), xx xxxxxx xxxxxx x xxxxxx, že xx xxxxxxx dostupných xxxxx xxxx xxxx xxxxx při xxxxxxx x xxxxxxxxxxx xx 0,3 % xxxxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx xxx xxxxxxxxxxxx bezpečná. X xxxxxxx xx xxxxxxxxxxx xxxxx Chloroacetamide xxxx xxxxx XXX xxxxxxxxx 2 a na xxxxxxxxxx XXXX xx xxxx xxx tato xxxxx xxxxxx ze xxxxxxx xxxxxxxxxxxxx xxxxxx povolených x xxxxxxxxxxxx přípravcích x xxxxxxx X xxxxxxxx (XX) x. 1223/2009 x xxxxxxxx xx xxxxxx xxxxx xxxxxxxxxx v kosmetických xxxxxxxxxxx x xxxxxxx XX xxxxxxxxx nařízení.

(8)

Xxxxx xxxxxxxxxxxxx xx x xxxxxxxx xxxx xxxxxxx v položce 7 xxxxxxx III xxxxxxxx (XX) x. 1223/2009 jako xxxxx povolená v kosmetických xxxxxxxxxxx v koncentraci xx 35 % x xxxxxxxxx připraveném x xxxxxxx. Xxxxxxxxxxxxx xxx xxxxx nařízení (XX) x. 1272/2008 klasifikován xxxx xxxxx XXX xxxxxxxxx 2. Tato xxxxxxxxxxx xx stala použitelnou xxxx 1. xxxxxxxxx 2010. X xxxxxxx s čl. 15 odst. 1 xxxxxx větou nařízení (XX) č. 1223/2009 xxxx xxx xxxxx xxxxxxxxxxxxx xxxx kategorie 2 xxxxxxx v kosmetických přípravcích, xxxx-xx zhodnocena XXXX x xxxxxxxx xxxx xxxxxxxx xxx xxxxxxx x xxxxxxxx xxxxxxxxxxx. Dne 11. prosince 2012 xxxxx XXXX vědecké xxxxxxxxxx xxxxxxxx se xxxxx xxxxxxxxxxxxx (7). Dne 25. xxxxxx 2015 vydal VVBS xxxx stanovisko (8), které xxxx revidováno xxx 28. xxxxx 2015. X xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxxx VVBS x xxxxxx, xx xxxxxxxxx xxxxxxxxxxxxxx x xxxxxxxxxxx xx 35 % x xxxxxx xx xxxxx x xxxx xxxxxxx xx xxxxxxxx xxxxxx xxxx xxxxxxxxxx za xxxxxxxx xxx xxxxxxxxxxxx. X xxxxxxx xx xxxxxxxxxxx xxxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 2 x xx xxxxxxxxxx VVBS x xxxxxxxx x xxxx, xx xxxxxx známa x xx xxxxxxxxxx XXXX posouzena xxxxx další xxxxxxx xxxxxxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx, xx tato látka xxxx xxx xxxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx x xxxxxxx XXX nařízení (XX) x. 1223/2009 x xxxxxxxx xx xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx v příloze XX xxxxxxxxx nařízení.

(9)

Látka xxxxxxxxxxx je x xxxxxxxx xxxx uvedena x xxxxxxx 13 přílohy III xxxxxxxx (ES) č. 1223/2009 xxxx xxxxx xxxxxxxx x xxxxxxxxxxx xxx tvrzení xxxxx x xxxxxxxxxxx do 5 % v přípravku xxxxxxxxxxx x xxxxxxx. X xxxxxxxx době xx také xxxxxxx x xxxxxxx 5 přílohy X xxxxxxxx (XX) č. 1223/2009 xxxx látka xxxxxxxx x xxxxxxxxxxx xxx xxxxx xxxxxxx x xxxxxxxxxxx do 0,1 % x x xxxxxx xxxxxxxxxxx x xxxxxxxxxxx xx 0,2 %. Xxxxxxxxxxx xxx xxxxxxxxxxxx xxxx látka XXX xxxxxxxxx 1X xxxxxxxxx Xxxxxx (XX) č. 605/2014 (9). Xxxx xxxxxxxxxxx xx xxxxx xxxxxxxxxxx xxx 1. xxxxx 2016. V souladu x xx. 15 xxxx. 2 druhým pododstavcem xxxxxxxx (XX) č. 1223/2009 xxxxx xxx xxxxx xxxxxxxxxxxxx jako xxxxx XXX xxxxxxxxx 1 A xxxx 1X x xxxxxxxxxxxx xxxxxxxxxxx xxxxxxxxx použity, xxxxx xxxx xxxx, xx xxxx klasifikovány xxxx xxxxx XXX, xxxxxxx určité xxxxxxxx xxxxxx xxxxxxxx, xx xxxxxx x xxxxxxxxx xxxxx xxxxxx xxxxxxxxxxxx látky, xx xxxx xxxxxx xxxxxx na xxxxxx xxxxxxx kategorie xxxxxxxxx xx xxxxxx xxxxxxxx x xx xxxx tato xxxxx VVBS xxxxxxxxxx x xxxxxxxx jako xxxxxxxx. Xxx 7. xxxxxxxxx 2014 xxxxxx XXXX xx xxxx xxxxxxxxxx (10) x xxxxxx, xx „xxx tvrzení nebo xxxxxxxx nehtů xxxxx xxx xxxxxxxx xxxxxxx xxxxxxxxx xxx tvrzení xxxxx v nejvyšší xxxxxxxxxxx xxxxxx 2,2 % xxxxxxx xxxxxxxxxxxx“. Xxxxxxx však xxxxxx xxxxxxxxx, xx xxxxxx x xxxxxxxxx žádné xxxxxx xxxxxxxxxxxx xxxxx xxx tvrzení nehtů, xxx xx být xxxxxxxxxxx xxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx x xxxxxxx XXX xxxxxxxx (ES) č. 1223/2009. Xxxxxxxx x xxxx, že xxxxxx xxxxxx žádost xx xxxx xxxxxxx xxxxxxxxxxxx, xxxx by xxx tato xxxxx xxxxxx ze seznamu xxxxxxxxxxxxx přísad xxxxxxxxxx x xxxxxxxxxxxx přípravcích x xxxxxxx X xxxxxxxxx xxxxxxxx. Xxxxxxxxxxx xx xxx xxx xxxxxx doplněn na xxxxxx xxxxx zakázaných x xxxxxxxxxxxx přípravcích x xxxxxxx XX xxxxxxxx (XX) x. 1223/2009.

(10)

Xxxxxxxxxx xxxxxxxx perborité x xxxxxxxxxxx xxxxx xxxxx xxxx xxxxx uvolňující xxxxxxx vodíku, xxxxx xxxx x xxxxxxxx době xxxxxxx x xxxxxxx 12 xxxxxxx III xxxxxxxx (XX) x. 1223/2009. Xxxx xxxxx xxxx xxxxxxxxxxxxx xxxx látky CMR xxxxxxxxx 1X xxxxxxxxx (XX) x. 790/2009. Xxxx xxxxxxxxxxx se xxxxx xxxxxxxxxxx ke xxx 1. xxxxxxxx 2010. Na použití xxxxxx látek v oxidačních xxxxxxxxxxx x xxxxxxx xxxxx xxxx xxxxxx xxxxxx x xxxxxxxxx čl. 15 xxxx. 2 xxxxxxx pododstavce xxxxxxxx (XX) x. 1223/2009. Xxx 22. xxxxxx 2010 xxxxxx VVBS xx svém xxxxxxxxxx (11) x xxxxxx, xx „xxxxxx xxxxxxx xxxxxx xxx xxxxx, xxxxx uvolňují xxxxxxx xxxxxx, xx xx xxxx vztahovat xx perboritan xxxxx x xxxxxxxx xxxxxxxxxx x xx xxxxxxx xxxxxxxxxxx sodných xxxx složky x xxxxxxxxxx xxxxxxxxxxx k barvení vlasů x xxxxxxxxxxx nejvýše 3 % xx xxxxx xxxxxxxxxxxxx xxxxxx xxx xxxxxx xxxxxxxxxxxx“. Xxxxxxx xxxx xxxxxx xxxxxxxxx, že xxxxxx x xxxxxxxxx xxxxx xxxxxx xxxxxxxxxxxx xxxxx xxx xxxxx xxxxxxx xxxxx, sloučeniny xxxxxxxx xxxxxxxxx x xxxxxxxxxxx xxxxx xx xxxx být xxxxxx xx seznamu xxxxx podléhajících xxxxxxx x xxxxxxx XXX xxxxxxxx (XX) x. 1223/2009 a doplněny xx xxxxxx xxxxx xxxxxxxxxx v kosmetických xxxxxxxxxxx x xxxxxxx XX uvedeného xxxxxxxx.

(11)

Xxxxx xxx x xxxxxx xxxxx, xxx byly xxxxxxxxxxxxx xxxx xxxxx XXX xxxxx nařízení (XX) x. 1272/2008 x xxx xxx xxxx xxxxxx xxxxxx x xxxxxxxxx xx. 15 xxxx. 1 druhé xxxx xxxxxxxx (XX) x. 1223/2009, xxxx xxxxxxxxx, že xxxxxxxx xxxxxxxxx v uvedeném xxxxxxxxxx xx xxxxxxx. Xx xx týká xxxxx Trimethylbenzoyl xxxxxxxxxxxxxxxxx xxxxx, Furfural x Xxxxxxxxxxxxxxx xxxxxxxxx.

(12)

Xxxxx xxxxxxx(2,4,6-xxxxxxxxxxxxxxx)xxxxxx xxxx, xxxxx název xxxxx XXXX xxx Xxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxx (XXX), xxxx x xxxxxxxx xxxx xx xxxxxx xxxxxxxx (XX) x. 1223/2009 xxxxxxxx. Xxxx xxxxx byla xxxxxxxxxxxxx xxxx xxxxx XXX kategorie 2 xxxxxxxxx Komise (EU) x. 618/2012 (12). Tato klasifikace xx xxxxx xxxxxxxxxxx xxx 1. xxxxxxxx 2013. Dne 27. xxxxxx 2014 vydal VVBS xxxxxxx stanovisko (13), v němž xxxxxx x xxxxxx, xx xxxxx XXX je xxxxxxxx při xxxxxxx xxxx přípravek x xxxxxxxx xxxxx x xxxxxxxxxxx do 5,0 %, xxxxx že xxx x xxxxx mírně xxxxxxxxxxxxxxx xxxx. Xxxxxxxx x xxxxxxxxxxxxxxxx xxxxxxx XXX xx xxxx a vysokému xxxxxx expozice x xxxxxxxx xxxxx s kůží xxx xxxxxxxx xxxxxxxxx xx xxxxx samotnými xxxxxxxxxxxx xx používání XXX xxxx xxx omezeno xx xxxxxxxxxxxxx xxxxxxxxx. X xxxxxxx xx xxxx xxxxxxxxxxx by xxxxx XXX xxxx xxx xxxxxxxx xx xxxxxx xxxxx xxxxxxxxxxxxx omezení x xxxxxxx III xxxxxxxx (XX) x. 1223/2009 xxx xxxxxxxxxxxxx použití x xxxxxxxxx xxxxxxx xxxxx x xxxxxxxxxxx xxxxxxx 5 %.

(13)

Xxxxx 2-xxxxxxxxxx, xxxxx xxxxx podle XXXX zní Xxxxxxxx, xx používá xxxx xxxxx nebo xxxxxxxxxx xxxxxx v kosmetických xxxxxxxxxxx x x xxxxxxxx době není xxxxxxxx xx xxxxxx xxxxxxxx (XX) č. 1223/2009. Xxxx xxxxx byla xxxxxxxxxxxxx jako látka XXX kategorie 2 xxxxx xxxxxxxx (ES) x. 1272/2008. Tato xxxxxxxxxxx xx stala xxxxxxxxxxx xxxx 1. xxxxxxxxx 2010. Xxx 27. xxxxxx 2012 dospěl XXXX xx xxxx xxxxxxxxxx (14) x xxxxxx, xx xxxxxxx látky Xxxxxxxx x xxxxxxxxxxx xx 10 xxx (0,001 %) v přípravku xxxxxxxxxxx k použití, včetně xxxxxxxxx xxx ústní xxxxxxx, xxxxxxxxxxxxx riziko xxx xxxxxx spotřebitele. X xxxxxxx xx xxxxxxxxxxx xxxxx Xxxxxxxx xxxx xxxxx XXX kategorie 2 a na stanovisko XXXX xx látka Xxxxxxxx x xxxxxxxxxxx xxxxxxx 0,001 % měla xxx xxxxxxxx na xxxxxx xxxxx xxxxxxxxxxxxx omezení x xxxxxxx III xxxxxxxx (XX) č. 1223/2009.

(14)

Látka xxxxxxxxxxxxxxxx-xxxxxxxx-xxxxxxxxxxxx (XXXX), jejíž xxxxx xxxxx XXXX xxx Xxxxxxxxxxxxxxx biguanide, xx x xxxxxxxx xxxx xxxxxxx xx xxxxxxx xxxx xxxxxxxxxxx xxxxxxx v položce 28 xxxxxxx X xxxxxxxx (XX) x. 1223/2009 x xxxxxxxxxxx xxxxxxx 0,3 %. Xxxx xxxxx byla xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 2 nařízením Xxxxxx (XX) x. 944/2013 (15). Xxxx xxxxxxxxxxx se xxxxx xxxxxxxxxxx xxx 1. xxxxx 2015. Dne 18. června 2014 xxxxxx XXXX xxxxxxxxxx (16), xx xxxxxx dospěl x xxxxxx, xx xx xxxxxxx xxxxxxxxxx xxxxx xxxxx látku XXXX xxxxxxxxx xx xxxxxxxxx xxx xxxxxxxxxxxx, pokud xx x xxxxxxxxxxx xxxxxxx 0,3 % xxxxxxx xxxx xxxxxxxxxxx xxxxxxx x xxxxxxxxxx xxxxxxxxxxx xxxxxxxxx. Ve xxxx xxxxxxxxxx xxxx XXXX xxxxxx dospěl x xxxxxx, že xxxxxxxx xxxxxxx xx xxxxx xxx xxxxxxxx xx xxxxx koncentraci xxxxxxx x/xxxx omezení, pokud xxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxxxx, a že jsou xxxxxxxxx studie dermální xxxxxxxx xxxxxxxx xx xxxxxxx reprezentativních xxxxxxxxxxxx xxxxxxxxx. Xxx 7. xxxxx 2017 xxxxxx XXXX xxxx xxxxxxxxxx (17), ve xxxxxx xxxxxx x xxxxxx, že xx xxxxxxx předložených xxxxx xx xxxxxxx XXXX jako xxxxxxxxxxx xxxxxxx xx všech xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxxxxxx xx 0,1 % považuje xx xxxxxxxx, xxx xxxx použití xx xxxxxxxx xx xxxxxxxxxxxx. X xxxxxxx xx klasifikaci XXXX jako xxxxx XXX kategorie 2 x xx xxxx stanovisko XXXX xx xxxxx XXXX xxxx být xxxxxxxx jako xxxxxxxxxxx xxxxxxx ve všech xxxxxxxxxxxx přípravcích, s výjimkou xxxxxxxx, xxx xxxxx xxxx x xxxxxxxx xxxx xxxxxxxxx xxxxxxxxx xxx xxxxxxxxxx, x xxxxxxxxxxx xxxxxxx 0,1 %. Xxxxxxxx xxxxxxxxx x xxxxxxx X xxxxxxxx (XX) x. 1223/2009 xx xxxxx xxxx xxx odpovídajícím xxxxxxxx xxxxxxx.

(15)

Pokud xxx x xxxxxx skupinu látek, xxxxx xxxx klasifikovány xxxx látky XXX xxxxx xxxxxxxx (XX) x. 1272/2008, xxxxx xxxxxx xx výjimečné použití x xxxxxxxxxxxx xxxxxxxxxxx nebyla xxxxxxxxxx. Tyto xxxxx xx měly xxx xxxxxxxx xx xxxxxx xxxxxxxxxx látek x xxxxxxx XX nařízení (ES) x. 1223/2009 a případně xxxxxx xx xxxxxxx látek xxxxxxxxxxxxx omezení xxxx xxxxxxxxxx látek x xxxxxxxxx XXX a V uvedeného xxxxxxxx. Xx xx týká xxxx xxxx některých xxxxxxxxx boru, xxxxx xxxx x xxxxxxxx xxxx xxxxxxx v položkách 1a x 1x xxxxxxx III xxxxxxxx (XX) č. 1223/2009.

(16)

Xxxxxxx xxxxxxxxxx xxxx, xxxxx xxxx v současné xxxx xxxxxxx x xxxxxxxxx 1x x 1x přílohy XXX xxxxxxxx (XX) x. 1223/2009, x xxxxxxxxxx-xxxxxxxxxxxxx byly xxxxxxxxx (XX) x. 790/2009 klasifikovány xxxx látky CMR xxxxxxxxx 1X. Xxxx xxxxxxxxxxx xx xxxxx xxxxxxxxxxx xx dni 1. xxxxxxxx 2010. V souladu x xx. 15 xxxx. 2 druhým xxxxxxxxxxxx xxxxxxxx (XX) č. 1223/2009 xxxxx xxx xxxxx xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 1 X xxxx 1X x xxxxxxxxxxxx xxxxxxxxxxx výjimečně použity, xxxxx xxxx xxxx, xx xxxx xxxxxxxxxxxxx xxxx xxxxx XXX, xxxxxxx určité xxxxxxxx. Xxx 22. června 2010 vydal XXXX xxxxxxxxxx (18), x xxxx xxxxxx x xxxxxx, xx xxxxxxx xxxxxxxxxx boru, xxxxx xxxx x xxxxxxxx xxxx uvedeny x xxxxxxxxx 1x x 1x xxxxxxx XXX xxxxxxxxx nařízení, xxxx xxx xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx za xxxxxxxx xxxxxxxx xxxxxxxx. Xxxxxxx xxxxxx podána xxxxxx xx xxxxxx xxxxxxx x xxxxxx xxxxxxxxx, xx nejsou k dispozici xxxxx vhodné xxxxxxxxxxxx xxxxx xxx účely xxxxxxxxxxxx použití xxxxxxxxx x xxxxxxx XXX xxxxxxxx (XX) č. 1223/2009, xxxx xx xxx uvedené xxxxxxxxxx xxxx vyňaty xx seznamu xxxxx xxxxxxxxxxxxx xxxxxxx x xxxxxxx XXX uvedeného xxxxxxxx x xxxxxxxx xx xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx v příloze II xxxxxxxx (XX) x. 1223/2009. Xxxxx xxx x xxxxxxxxxx-xxxxxxxxxxxxx, xxxxxx xxxxxx xxxxxx xx xxxxxx použití x XXXX xx xxxxxxxxx xxxx bezpečnou. Xxxxxxx xxxxx xx xxxxx xxxx xxx xxxxxxxx xx xxxxxx látek xxxxxxxxxx x xxxxxxxxxxxx přípravcích x xxxxxxx XX xxxxxxxx (XX) x. 1223/2009.

(17)

Xxxxxxxxxx xx. 31 xxxx. 1 nařízení (XX) x. 1223/2009 stanoví, xx xxxxxxxxxxx-xx xxxxxxx určitých xxxxx v kosmetických přípravcích xxxxxxxxxxx riziko xxx xxxxxx xxxxxx, xxxxx xxxxxxxx kroky xx xxxxxx Společenství, může Xxxxxx po xxxxxxxxxx x XXXX xxxxxxxxxxxxx způsobem xxxxxx xxxxxxx XX xx XX xxxxxxxxx xxxxxxxx. Komise konzultovala XXXX xxxxxxx bezpečnosti xxxxxxxx xxxxx, které xxxx x xxxxxxxxxx hlediska xxxxxxx látkám klasifikovaným xxxx látky CMR xxxxxxxxx 1 X, 1X xxxx 2. Xx xx týká xxxxxxxx xxxxxxxxx xxxx, xxxxx x xxxxx paraformaldehyd a methylenglykol.

(18)

Xxxxxxx xxxxxxxxxx xxxx, x xxxxxxxx xxxx uvedené v položkách 1x x 1x přílohy XXX nařízení (XX) x. 1223/2009, xxxx xxx xxxxxxxxxx xxxxxxx v 16. xxxx xxxxxxxxxx, xxxxxx xxxxxxxxxxxxx xxxx xxxxx XXX. Xxx 12. prosince 2013 xxxxx VVBS xxxxxxxxxx xxxxxxxx xx xxxxxxxx, xxxxxxxxxxxxx a oktaboritanů (19), xx xxxxxx xxxxxx x xxxxxx, xx xx xxxxxxx xxxxx, xxxxxx xxxx xxxxxxx xxxx xxxx xxxxxx xxxxxxxx xxxxxx, xxxx xx MEA-borát, XXXX-xxxxxxx, xxxxxxx xxxxxxxx, xxxxxxxxxxxxxxx-xxxxx x xxxxxxx zinečnatý, xxxxxxxxx xx xxxxxxx xxxxxxxxx xx xxxxxxxx xxxxxxx, x xxxxx xx xx xxxxxx xxxxxxx xxxxxx xxx xxxxxxxx xxxxxxx xxxx xxxxxxxxx xx xxxxx xxxxxxx xxxxxxxx, tetraboritanů x xxxxxxxxxxxx. Xxxxxxxx boritá byla xxxxxxxxx (ES) x. 790/2009 xxxxxxxxxxxxx xxxx látka XXX xxxxxxxxx 1B. Xxxx xxxxxxxxxxx se xxxxx použitelnou xx xxx 1. prosince 2010. Celá xxxxxxx xxxxxxxx, xxxxxxxxxxxxx x xxxxxxxxxxxx, x xxxxxxxx xxxxx x xxxxxxx xxxxxxx, které xxxx xxxxxxxxxxxxx jako xxxxx XXX, xxxxxx xxxx xxxxxxx soli xxxx xxxxxx xxxxxxxx xxxxxx by xxxx xxx x xxxxxxx xx xxxxxxxxxx XXXX xxxxxx xx seznamu xxxxx xxxxxxxxxxxxx omezení v příloze XXX nařízení (XX) x. 1223/2009 x xxxxxxxx xx xxxxxx látek zakázaných x xxxxxxxxxxxx přípravcích x xxxxxxx XX xxxxxxxxx xxxxxxxx.

(19)

Xxxxx xxxxxxxxxxxxxxx xx x xxxxxxxx xxxx xxxxxxx xx xxxxxxx v položce 5 xxxxxxx V nařízení (XX) x. 1223/2009, xxxxx xx xxxxxx xx xxxxxxxxxxxx xxxxxx xxxxxxxxxxxxx jako xxxxx XXX. Xxxxx xxxxxxxxxxxxxx není x xxxxxxxx xxxx do xxxxxx xxxxxxxx (ES) x. 1223/2009 xxxxxxxx. Ve dnech 26. x 27. xxxxxx 2012 xxxxxx XXXX stanovisko xxxxxxxx xx xxxxxxxxxxxxxxx (20), ve xxxxxx xxxxxxxx, xx xxxxxxxxxxxxxx xx xx xxxx xxxxxxx podmínek xxxxxx xxxxxxxxxxxx, xxx xxxx x xxxx xxxxxxx xx formaldehyd ve xxxxxxx roztocích, x xx xxxxxxxxxxxxxxx xxxx xxxxxxxxxxxxxxx, xxx vede k jeho xxxxxxx na xxxxxxxxxxx xxxxxxxx xxxx xxxxxxx. X xxxxxxx na stanovisko XXXX existuje potenciální xxxxxx xxx xxxxxx xxxxxx xxxxxxxxxxx x xxxxxxx xxxxxx látek x xxxxxxxxxxxx xxxxxxxxxxx. Xxxxxxxxxxxxxxx xx xxxxx xxx být xxxxx xx xxxxxxx xxxxxxxxxxxxx přísad xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx v příloze X xxxxxxxx (XX) x. 1223/2009 x xxxxxxxxxxxxxxx x xxxxxxxxxxxxxx xx xxxx xxx doplněny xx xxxxxx xxxxx xxxxxxxxxx v kosmetických přípravcích x xxxxxxx II xxxxxxxxx xxxxxxxx.

(20)	Xxxxxxxx (XX) x. 1223/2009 xx xxxxx xxxx xxx xxxxxxxxxxxxx xxxxxxxx xxxxxxx.

(21)	Xxxxxxxx xxxxxxxxx xxxxx xxxxxxxxx xxxx x xxxxxxx xx xxxxxxxxxxx Stálého xxxxxx xxx xxxxxxxxxx xxxxxxxxx,

XXXXXXX XXXX XXXXXXXX:

Xxxxxx 1

Xxxxxxx XX, XXX x X xxxxxxxx (XX) č. 1223/2009 xx xxxx v souladu x xxxxxxxx tohoto xxxxxxxx.

Xxxxxx 2

Xxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxxxxxx xxxx xx xxxxxxxxx x Xxxxxxx xxxxxxxx Evropské unie.

Xxxx xxxxxxxx xx xxxxxxx x xxxxx xxxxxxx x xxxxx xxxxxxxxxx ve xxxxx xxxxxxxxx státech.

X Xxxxxxx xxx 22. xxxxxx 2019.

Xx Xxxxxx

xxxxxxxx

Xxxx-Xxxxxx JUNCKER

(1)&xxxx;&xxxx;Xx.&xxxx;xxxx.&xxxx;X&xxxx;342, 22.12.2009, x.&xxxx;59.

(2)&xxxx;&xxxx;Xxxxxxxx Evropského xxxxxxxxxx x&xxxx;Xxxx (XX) č. 1272/2008 xx xxx 16.&xxxx;xxxxxxxx&xxxx;2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx a směsí, x&xxxx;xxxxx x&xxxx;xxxxxxx xxxxxxx 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxxxx xxxxxxxx (XX) x.&xxxx;1907/2006 (Xx.&xxxx;xxxx.&xxxx;X&xxxx;353, 31.12.2008, x.&xxxx;1).

(3)&xxxx;&xxxx;Xxxxxxxx Xxxxxx (XX) 2017/776 ze dne 4.&xxxx;xxxxxx&xxxx;2017, xxxxxx xx xxx účely xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (ES) č. 1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx a směsí (Xx.&xxxx;xxxx.&xxxx;X&xxxx;116, 5.5.2017, x.&xxxx;1).

(4)&xxxx;&xxxx;Xxxxxxxx Komise (XX) x.&xxxx;790/2009 xx dne 10.&xxxx;xxxxx&xxxx;2009, xxxxxx xx xxx xxxxx xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx mění xxxxxxxx Evropského xxxxxxxxxx x&xxxx;Xxxx (ES) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, označování x&xxxx;xxxxxx xxxxx a směsí (Xx.&xxxx;xxxx.&xxxx;X&xxxx;235, 5.9.2009, x.&xxxx;1).

(5)&xxxx;&xxxx;XXXX/1344/10, http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_077.pdf.

(6)&xxxx;&xxxx;XXXX/1360/10, xxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_053.xxx.

(7)&xxxx;&xxxx;XXXX/1408/11, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_118.xxx

(8) SCCS/1547/15, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_170.xxx

(9)&xxxx;&xxxx;Xxxxxxxx Xxxxxx (XX) x.&xxxx;605/2014 ze xxx 5.&xxxx;xxxxxx&xxxx;2014, xxxxxx xx xxx účely xxxxxxxx xxxxxxxxxxxx výrazů týkajících xx nebezpečnosti a bezpečného xxxxxxxxx x&xxxx;xxxxxxxxxxxx x&xxxx;xxxxxxxxxxxx xxxxxxx-xxxxxxxxxxx pokroku mění xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (ES) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx (Xx.&xxxx;xxxx.&xxxx;X&xxxx;167, 6.6.2014, s. 36).

(10)&xxxx;&xxxx;XXXX/1538/14, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_164.xxx

(11)&xxxx;&xxxx;XXXX/1345/10, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_031.xxx

(12) Nařízení Komise (XX) x.&xxxx;618/2012 ze dne 10.&xxxx;xxxxxxxx&xxxx;2012, xxxxxx xx xxx účely xxxxxxxxxxxx xxxxxxx-xxxxxxxxxxx pokroku xxxx xxxxxxxx Evropského xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx (Xx.&xxxx;xxxx.&xxxx;X&xxxx;179, 11.7.2012, x.&xxxx;3).

(13)&xxxx;&xxxx;XXXX/1528/14, xxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_149.xxx.

(14)&xxxx;&xxxx;XXXX/1461/12, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_083.xxx

(15)&xxxx;&xxxx;Xxxxxxxx Xxxxxx (XX) x.&xxxx;944/2013 ze xxx 2.&xxxx;xxxxx&xxxx;2013, xxxxxx se xxx účely xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) č. 1272/2008 x&xxxx;xxxxxxxxxxx, označování x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx (Xx.&xxxx;xxxx.&xxxx;X&xxxx;261, 3.10.2013, x.&xxxx;5).

(16)&xxxx;&xxxx;XXXX/1535/14, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_157.pdf

(17)&xxxx;&xxxx;XXXX/1581/16, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxx/xxxxxx/xxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_204.xxx

(18)&xxxx;&xxxx;XXXX/1249/09, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_027.xxx

(19) SCCS/1523/13, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_146.xxx

(20)&xxxx;&xxxx;XXXX/1483/12, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_097.xxx

XXXXXXX

1)&xxxx;&xxxx;&xxxx;

Xxxxxxx XX xx xxxx takto:

doplňují xx xxxx xxxxxxx, které xxxxx:

Xxxxxxxxxx číslo	Identifikace xxxxx
Xxxxxxxxxx číslo	Xxxxxxxx xxxxx/XXX	Xxxxx XXX	Xxxxx XX
x	x	x	x
„1385	Xxx-1-(3-xxxxxxxxxx)-3,5,7-xxxxxx-1-xxxxxxxxxxxxxxx-xxxxxxx (xxx-XXXX)	51229-78-8	426-020-3
1386	Xxx-1-(3-xxxxxxxxxx)-3,5,7-xxxxxx-1-xxxxxxxxxxxxxxx-xxxxxxx (xxx-XXXX), xxxxxxxxxx-15	51229-78-8	426-020-3
1387	2-Xxxxxxxxxxxxx	79-07-2	201-174-2
1388	Xxxxxxxxxxxxxxxxxxxxxxxxxxx	556-67-2	209-136-7
1389	Xxxxxxxxxxxxx; xxxxxxxxxxxxxxx	75-09-2	200-838-9
1390	2,2′-((3,3′,5,5′-xxxxxxxxxxx-(1,1′-xxxxxxx)-4,4′-xxxx)-xxx(xxxxxxxxxxx))-xxxxxxxxx	85954-11-6	413-900-7
1391	Xxxxxxxxxxx; xxxxxxx	75-07-0	200-836-8
1392	1-Xxxxxxxxxxx-6,7-xxxxxxx-4-xxx-1,4-xxxxxxxxxxxxxxx-3-xxxxxxxxxxx xxxxxxxx	93107-30-3	413-760-7
1393	X-xxxxxx-2-xxxxxxxxxx; 1-xxxxxxxxxxxxxxxx-2-xx	872-50-4	212-828-1
1394	Xxxxxxxxxxxx; xxxx xxxxxx	1303-86-2	215-125-8
1395	Xxxxxxxx xxxxxx [1] Xxxxxxxx xxxxxx [2]	10043-35-3 [1] 11113-50-1 [2]	233-139-2 [1] 234-343-4 [2]
1396	Xxxxxxxx, tetraboritany, xxxxxxxxxxxx x xxxx x xxxxxx xxxxxxxx xxxxxx, včetně:
	Oktaboritan xxxxxxx xxxxxxxxxxx [1]	12280-03-4 [1]	234-541-0 [1]
	2-xxxxxxxxxxxx, xxxxxxxxx x xxxxxxxxx boritou [2]	10377-81-8 [2]	233-829-3 [2]
	(2-hydroxypropyl)amoniumdihydrogenorthoboritan [3]	68003-13-4 [3]	268-109-8 [3]
	Xxxxxxx xxxxxxxx, xxxxxxxx xxx xxxxxxxx xxxxxx [4]	12712-38-8 [4]	603-184-6 [4]
	Xxxxxxxxxxxxxxx-xxxxx [5]	-[5]	— [5]
	Xxxxxxx xxxxxxxxx [6]	1332-07-6 [6]	215-566-6 [6]
	Xxxxxxx xxxxx, xxxxxxxxxxxx xxxxxxx xxxxxxx; xxxxx xxx xxxxxxxx xxxxxx [7]	1330-43-4 [7]	215-540-4 [7]
	Heptaoxid xxxxxxx-xxxxxxxxxxx hydrát [8]	12267-73-1 [8]	235-541-3 [8]
	Xxxxx sůl xxxxxxxx xxxxxxxxxxx [9]	13840-56-7 [9]	237-560-2 [9]
	Tetraboritan xxxxxxx xxxxxxxxxx; xxxxx dekahydrát [10]	1303-96-4 [10]	215-540-4 [10]
	Xxxxxxxxxxxx xxxxxxx xxxxxxxxxxx; xxxxx xxxxxxxxxxx [11]	12179-04-3 [11]	215-540-4 [11]
1397	Xxxxxxxxxx sodný [1] xxxxxxxxxxxxxxxxx xxxxx; xxxxxxxxxxxxx sodný [2]	15120-21-5 [1]	239-172-9 [1]
1397		7632-04-4 [2] 10332-33-9 [2] 10486-00-7[2]	231-556-4 [2]
1398	Xxxxxxxx xxxxxxxxx (H3BO2(O2)), xxxxxxxxx xxx, xxxxxxxxx [1]	13517-20-9 [1]	239-172-9 [1]
	kyselina perboritá, xxxxx sůl, tetrahydrát [2]	37244-98-7 [2]	234-390-0 [2]
	xxxxxxxx xxxxxxxxx (XXX(X2)), xxxxx xxx, xxxxxxxxxxx peroxyboritan xxxxx hexahydrát [3]	10486-00-7 [3]	231-556-4 [3]
1399	Xxxxxxxx perboritá, xxxxx xxx [1]	11138-47-9 [1]	234-390-0 [1]
	xxxxxxxx xxxxxxxxx, xxxxx xxx, xxxxxxxxxx [2]	12040-72-1 [2]	234-390-0 [2]
	xxxxxxxx xxxxxxxxx (HBO(O2)), xxxxx xxx, xxxxxxxxxx [3]	10332-33-9 [3]	231-556-4 [3]
1400	Dibutylcín-hydrogenborát	75113-37-0	401-040-5
1401	Tetrafluoroboritan xxxxxxxxx	14708-14-6	238-753-4
1402	Xxxxxxxx (XXX); mangan-N,N′-ethylenbis(dithiokarbamát), xxxxxxxxx xxxxxxx se zinečnatou xxxx	8018-01-7	616-995-5
1403	Xxxxx (XXX); xxxxxx-X,X′-xxxxxxxxxx(xxxxxxxxxxxxxx) (xxxxxxxxx)	12427-38-2	235-654-8
1404	Xxxxxxxxxxx (XXX); ethyl-N-[({[(2,2-dimethyl-2,3-dihydro-1-benzofuran-7-yl)oxy]karbonyl} xxxxxxxxxxx)xxxxxxxx]-X-xxxxxxxxx-β-xxxxxxxx	82560-54-1	617-356-3
1405	X-xxxxxxxx-X-xxxxxx xxxxxxxxxxxxxxxxxxxx	103122-66-3	434-350-4
1406	Xxxxxxxxxxx (XXX); xxxxxxxxx-3-xxxxxxxxxxxxxxx	101-21-3	202-925-7
1407	Xxxxx-X-(xxxxxxxxxxxxxx)xxxxxxxxxxxx	109202-58-6	432-750-3
1408	Xxxxxxxxxxxxxxx-xxxxxx	13465-08-2	236-691-2
1409	(4-Xxxxxxxxxxx)[3-(3-xxxxxx-4-xxxxxxxxxx)xxxxxx]xxxxxxxxxxxxx	105024-66-6	405-020-7
1410	Xxxxx (ISO); xxxxxxx-X-[xxxxx(xxxx)xxxxxx]xxxxxxxxxxxx	14816-18-3	238-887-3
1411	Xxxxxxxxxx xxxxxx (ISO); amonium-2-amino-4-[hydroxy (xxxxxx)xxxxxxxx]xxxxxxxx	77182-82-2	278-636-5
1412	Xxxxxxx směs: xxxxxxxx-{2-[X-(xxxxxxxxxxxxx)xxxxxxxxx]xxxxx}xxxxxxxx; xxxxxxx-{2-[X-(xxxxxxxxxxxxx)xxxxxxxxx]xxxxx}xxxxxxxx; xxxxx-xxxxxx-{2-[X-(xxxxxxxxxxxxx)xxxxxxxxx]xxxxx}xxxxxxxx	—	435-960-3
1413	(4-Xxxxxxxxxx)xxxxxxxxx xxxxxxxx	86552-32-1	420-450-5
1414	Xxxxxxx xxxx: 4,7-xxx(xxxxxxxxxxxxxx)-3,6,9-xxxxxxx-1,11-xxxxxxxxxxxxxx; 4,8-bis(merkaptomethyl)-3,6,9-trithia-1,11-undekandithiol; 5,7-xxx(xxxxxxxxxxxxxx)-3,6,9-xxxxxxx-1,11-xxxxxxxxxxxxxx	170016-25-8	427-050-1
1415	Xxxxxxxxxxx xxxxxxxxxx-xxxxxxxxxxxxxx(X2Xx6X13)	12056-51-8	432-240-0
1416	Xxxxx xxxxxxxxxx	71-48-7	200-755-8
1417	Xxxxxxxx xxxxxxxxxx	10141-05-6	233-402-1
1418	Xxxxxxxxx kobaltnatý	513-79-1	208-169-4
1419	Chlorid xxxxxxxxx	7718-54-9	231-743-0
1420	Xxxxxxxx xxxxxxxxx [1]	13138-45-9 [1]	236-068-5 [1]
1420	xxxxxxxx xxxxxxx, sůl xxxxx [2]	14216-75-2 [2]	238-076-4 [2]
1421	Xxxxxxx xxxxxxx (lech)	69012-50-6	273-749-6
1422	Bahna x xxxx z xxxxxxxxxxxxxx xxxxxxxx xxxx, xxxxxxx xxxx, x xxxxxxx síranu xxxxxxxxxxx	92129-57-2	295-859-3
1423	Xxxxx x xxxx z xxxxxxxxxxxxxx xxxxxxxx mědi, xxxxxxx mědi	94551-87-8	305-433-1
1424	Chloristan xxxxxxxxx; xxxxxxxx chloristá, xxxxxxxxx xxx	13637-71-3	237-124-1
1425	Xxxxx xxxxxxxxxx-xxxxxxxxx [1]	13842-46-1 [1]	237-563-9 [1]
1425	xxxxx xxxxxxxx-xxxxxxxxx [2]	15699-18-0 [2]	239-793-2 [2]
1426	Xxxx-xxx(xxxxxxxxxx); xxxx-xxxxxxxx	13770-89-3	237-396-1
1427	Xxxxxxxxxxxxxxxxxx nikelnatý	14708-14-6	238-753-4
1428	Nikl-diformiát [1]	3349-06-2 [1]	222-101-0 [1]
	mravenčí kyselina, xxx xxxxx [2]	15843-02-4 [2]	239-946-6 [2]
	xxxxxxxx xxxxxxxx, xxx xxxx x xxxxx [3]	68134-59-8 [3]	268-755-0 [3]
1429	Xxxx-xxxxxxxx [1]	373-02-4 [1]	206-761-7 [1]
1429	xxxx-xxxxxx [2]	14998-37-9 [2]	239-086-1 [2]
1430	Xxxx(XX)-xxxxxxxxx	553-71-9	209-046-8
1431	Xxxx-xxx(4-xxxxxxxxxxxxxxxxxx)	3906-55-6	223-463-2
1432	Xxxx(XX)-xxxxxxx; nikl(II)-stearát	2223-95-2	218-744-1
1433	Nikl-dilaktát	16039-61-5	—
1434	Nikl(II)-oktanoát	4995-91-9	225-656-7
1435	Fluorid nikelnatý [1]	10028-18-9 [1]	233-071-3 [1]
	bromid xxxxxxxxx [2]	13462-88-9 [2]	236-665-0 [2]
	xxxxx xxxxxxxxx [3]	13462-90-3 [3]	236-666-6 [3]
	xxxxxxx draselno-nikelnatý [4]	11132-10-8 [4]	- [4]
1436	Xxxxxxxxxxxxxxxxxxxx xxxxxxxxx	26043-11-8	247-430-7
1437	Xxxxxxx xxxxxxxxx	15060-62-5	239-125-2
1438	Xxxxxxxxxxxxxxxxxxx xxxxxxxxx [1]	14332-34-4 [1]	238-278-2 [1]
	bis(dihydrogenfosforečnan) xxxxxxxxx [2]	18718-11-1 [2]	242-522-3 [2]
	xxxxxxxxxxxxxxxx xxxxxxxxx [3]	10381-36-9 [3]	233-844-5 [3]
	xxxxxxxxxxxxx dinikelnatý [4]	14448-18-1 [4]	238-426-6 [4]
	xxx(xxxxxxxxx) xxxxxxxxx [5]	14507-36-9 [5]	238-511-8 [5]
	xxxxxxxxxxxx xxxxx [6]	36026-88-7 [6]	252-840-4 [6]
	xxxxxxxx xxxxxxxxxx, xxx xxxxxxx a xxxxx [7]	17169-61-8 [7]	- [7]
	xxxxxxxx xxxxxxxxxxxx, xxxxxxxxx xxx [8]	19372-20-4 [8]	— [8]
1439	Xxxxxxxxxxxxxxxxxxxxx xxxxxxxx-xxxxxxxxx	74195-78-1	—
1440	Xxxxxx xxxxxxxxx	557-19-7	209-160-8
1441	Xxxxxxx xxxxxxxxx	14721-18-7	238-766-5
1442	Xxxxxxxxxx xxxxxxxxx [1]	21784-78-1 [1]	244-578-4 [1]
	orthokřemičitan xxxxxxxxxxx [2]	13775-54-7 [2]	237-411-1 [2]
	xxxxxxxxxx xxxxxxxxx (3:4) [3]	31748-25-1 [3]	250-788-7 [3]
	xxxxxxxx křemičitá, xxx xxxxx [4]	37321-15-6 [4]	253-461-7 [4]
	xxxxxxxxxxx-xxxxxxxxxx [xxxxxxxxxxxxx(4-)]xxxxxxxxxxxx(3-)xxxxxxxx [5]	12519-85-6 [5]	235-688-3 [5]
1443	Xxxxxxxxxxxxxxxxxxxxx xxxxxxxxxxx	14874-78-3	238-946-3
1444	Xxxxxxxxxxxxx xxxxxxxxxxxx; xxxxxxxxxx xxxxxxxxx	13477-70-8	236-771-7
1445	Xxxx(XX)-xxxxxx [1]	547-67-1 [1]	208-933-7 [1]
1445	xxxxxxxxx xxxxxxxx, xxx xxxxx [2]	20543-06-0 [2]	243-867-2 [2]
1446	Xxxxxxxx nikelnatý	12142-88-0	235-260-6
1447	Tetrasulfid xxxxxxxx	12137-12-1	—
1448	Xxxxxxxxxxxx xxxxxxxxxxxx	74646-29-0	—
1449	Xxxx periklas x xxxxxxx xxxxx x xxxxxxx; X.X. pigmentová xxxx 25; C.I. 77332 [1]	68186-89-0 [1]	269-051-6 [1]
	xxxxxx xxxxxxxxxx-xxxxxxxxx [2]	58591-45-0 [2]	261-346-8 [2]
	xxxx xxxxxxx x xxxxx [3]	12737-30-3 [3]	620-395-9 [3]
1450	Xxxxxxx xxxxxxxxx-xxxxxxxx; xxxxxxxxx xxxxxxxxx	12035-38-0	234-824-9
1451	Xxxxxxxx xxxxxxxxx-xxxxxxxxxx	15780-33-3	239-876-6
1452	Xxxxxxxxxxxxxx xxxxxxxxx	13689-92-4	237-205-1
1453	Xxxxxxxxx xxxxxxxxx	15586-38-6	239-646-5
1454	Xxxxxxxxxxx nikelnatý	10101-96-9	233-263-7
1455	Selenid xxxxxxxxx	1314-05-2	215-216-2
1456	Xxxxxxxx xxxxxxxxx, xxx xxxxx x niklu	68130-19-8	—
1457	Diarsenid xxxxx [1]	12068-61-0 [1]	235-103-1 [1]
1457	xxxxxxx xxxxx [2]	27016-75-7 [2]	248-169-1 [2]
1458	Xxxxxx xxxxx xxxxxxxx x xxxxxxx xxxxx, xxxxx x xxxxxx; C.I. pigmentová xxxx 157; X.X. 77900	68610-24-2	271-853-6
1459	Xxxxxxxxxx xxxxxxxxx [1]	67952-43-6 [1]	267-897-0 [1]
	bromičnan xxxxxxxxx [2]	14550-87-9 [2]	238-596-1 [2]
	ethyl-hydrogen-sulfát, xxxxxxxxx sůl [3]	71720-48-4 [3]	275-897-7 [3]
1460	Xxxx(XX)-xxxxxxxxxxxxxx [1]	16083-14-0 [1]	240-235-8 [1]
	xxxx(XX)-xxxxxxxxx [2]	3349-08-4 [2]	222-102-6 [2]
	xxxx-xxx(xxxxxxxxxxxxxx) [3]	39819-65-3 [3]	254-642-3 [3]
	nikl(II)-hydrogen-citrát [4]	18721-51-2 [4]	242-533-3 [4]
	xxxxxxxxx xxxxxxxx, xxxxxxxxxxxxxxx xxx [5]	18283-82-4 [5]	242-161-1 [5]
	xxxxxxxxx xxxxxxxx, xxx xxxxx [6]	22605-92-1 [6]	245-119-0 [6]
	xxxx-[xxx(2-xxxxxxxxxxxxx)] [7]	4454-16-4 [7]	224-699-9 [7]
	2-ethylhexanová kyselina, xxx niklu [8]	7580-31-6 [8]	231-480-1 [8]
	dimethylhexanová xxxxxxxx, xxx xxxxx [9]	93983-68-7 [9]	301-323-2 [9]
	xxxx(XX)-xxxxxxxxxxx [10]	29317-63-3 [10]	249-555-2 [10]
	xxxxxxxxxxx kyselina, xxx xxxxx [11]	27637-46-3 [11]	248-585-3 [11]
	nikl-diisononanoát [12]	84852-37-9 [12]	284-349-6 [12]
	xxxx(XX)-xxxxxxxxxxx [13]	93920-10-6 [13]	300-094-6 [13]
	xxxx(XX)-xxxxxxxxxxx [14]	85508-43-6 [14]	287-468-1 [14]
	nikl(II)-neodekanoát [15]	85508-44-7 [15]	287-469-7 [15]
	xxxxxxxxxxx kyselina, xxx xxxxx [16]	51818-56-5 [16]	257-447-1 [16]
	xxxx(XX)-xxxxxxxxxxxxx [17]	93920-09-3 [17]	300-093-0 [17]
	xxx(X-xxxxxxxxx-X 1,X 2)xxxx [18]	71957-07-8 [18]	276-205-6 [18]
	xxxx-xxx(3,5-xx-xxxx-xxxxx-4-xxxxxxxxxxxxxx (1:2) [19]	52625-25-9 [19]	258-051-1 [19]
	nikl(II)-palmitát [20]	13654-40-5 [20]	237-138-8 [20]
	(2-xxxxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [21]	85508-45-8 [21]	287-470-2 [21]
	(isononanoato-O)(isooktanoato-O)nikl [22]	85508-46-9 [22]	287-471-8 [22]
	(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [23]	84852-35-7 [23]	284-347-5 [23]
	(2-xxxxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [24]	84852-39-1 [24]	284-351-7 [24]
	(2-xxxxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [25]	85135-77-9 [25]	285-698-7 [25]
	(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [26]	85166-19-4 [26]	285-909-2 [26]
	(isodekanoato-O)(isononanoato-O)nikl [27]	84852-36-8 [27]	284-348-0 [27]
	(isononanoato-O)(neodekanoato-O)nikl [28]	85551-28-6 [28]	287-592-6 [28]
	mastné xxxxxxxx, X6-19 xxxxxxxxxx, xxxx xxxxx [29]	91697-41-5 [29]	294-302-1 [29]
	xxxxxx xxxxxxxx, C8-18 x nenasycené X18, xxxx xxxxx [30]	84776-45-4 [30]	283-972-0 [30]
	naftalen-2,7-disulfonová xxxxxxxx, xxxxxxxxx sůl [31]	72319-19-8 [31]	[31]
1461	Xxxxxxxxx xxxxxxxxx [1]	7757-95-1 [1]	231-827-7 [1]
	xxxxxxx nikelnato-telluričitý [2]	15851-52-2 [2]	239-967-0 [2]
	xxxxxxxxx xxxxxxxxx-xxxxxxxxx [3]	15852-21-8 [3]	239-974-9 [3]
	xxxxxxxxxxx-xxxxxxxx-xxxx xxxxxxxxx x xxxxx [4]	68130-36-9 [4]	268-585-7 [4]
1462	Xxxxx xxxxx (NiB) [1]	12007-00-0 [1]	234-493-0 [1]
	xxxxx xxxxxxx [2]	12007-01-1 [2]	234-494-6 [2]
	xxxxx triniklu [3]	12007-02-2 [3]	234-495-1 [3]
	xxxxx niklu [4]	12619-90-8 [4]	235-723-2 [4]
	xxxxxxx xxxxxxxxx [5]	12059-14-2 [5]	235-033-1 [5]
	xxxxxxxxx niklu [6]	12201-89-7 [6]	235-379-3 [6]
	xxxxxx diniklu [7]	12035-64-2 [7]	234-828-0 [7]
	xxxxxx xxxxx a xxxx [8]	65229-23-4 [8]	[8]
1463	Xxxxxxxxx nikelnato-dihlinitý [1]	12004-35-2 [1]	234-454-8 [1]
	xxxxxxx xxxxxxxxx-xxxxxxxxxx [2]	12035-39-1 [2]	234-825-4 [2]
	xxxx xxxxx a xxxxxx [3]	12653-76-8 [3]	235-752-0 [3]
	xxxxxxxx nikelnato-divanadičný [4]	52502-12-2 [4]	257-970-5 [4]
	oktaoxid xxxxxxxxxx-xxxxxxxxx-xxxxxxxxxxxxx [5]	68016-03-5 [5]	268-169-5 [5]
	xxxxxxx xxxxxxxxx-xxxxxxxxxxx [6]	70692-93-2 [6]	274-755-1 [6]
	xxxxxxxxx xxxxxxxxx-xxxxxxxxxxx [7]	14177-55-0 [7]	238-034-5 [7]
	xxxxxxxxx xxxxxxxxx-xxxxxxxxxx [8]	14177-51-6 [8]	238-032-4 [8]
	olivín, xxxxxxx xxxxx [9]	68515-84-4 [9]	271-112-7 [9]
	xxxxxx dilithno-nikelnatý [10]	12031-65-1 [10]	620-400-4 [10]
	xxxx xxxxxxxxx a xxxxx [11]	12673-58-4 [11]	— [11]
1464	Kobalt-lithium-nikl-oxid	—	442-750-5
1465	Oxid xxxxxxxxxxx	1313-27-5	215-204-7
1466	Xxxxxxxxxxxxxxxxxxx (XXXX)	683-18-1	211-670-0
1467	4,4′-xxx(X-xxxxxxxxx-4-xxxxxxxxxxxxxxxxxxxxxx) xxxxxxxxxxxxx	151882-81-4	418-770-5
1468	Xxxxxxxxxxxxxxx; (2-xxxxx)xxxxxxxx	98-00-0	202-626-1
1469	1,2-Xxxxx-4-(1,2-xxxxxxxxxx)xxxxxxxxxx; 4-xxxxxxxxxxxxxxxxxxxxxxx	106-87-6	203-437-7
1470	6-Xxxxxxxxxxxxxxx-1-xx-xxxxxxxxxxxxxxx	27610-48-6	429-960-2
1471	2-(2-Xxxxxxxxxxxxxxx)xxxxxxx (XXXX)	111-41-1	203-867-5
1472	1,2-Xxxxxxxxxxxxx	629-14-1	211-076-1
1473	(2,3-Xxxxxxxxxxx)xxxxxxxxxxxxxxxx-xxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx	3033-77-0	221-221-0
1474	1-(2-Xxxxx-5-xxxxxxxxxx)-2,2,2-xxxxxxxxxxxxx-1,1-xxxx-xxxxxxxxxxxx	214353-17-0	433-580-2
1475	(X)-3-[1-[4-[2-(xxxxxxxxxxxxx)xxxxxx]xxxxx]-2-xxxxxxxx-1-xxxx]xxxxx	82413-20-5	428-010-4
1476	4,4′-[1,3-Xxxxxxxxxx(1-xxxxxxxxxxxxx)]xxxxxxx	13595-25-0	428-970-4
1477	2-Xxxxx-6-xxxxxxxxxx	2040-90-6	433-890-8
1478	5-Xxxx-xxxxx-2-xxxxxxxxxxxx-1-xxxxx	—	444-970-7
1479	2-Xxxxxxx-3-xxxxxxx-5-xxxxxxxxxxxxxx-3-xx-xxxxxxxx-2-xx-1-xx	94723-86-1	425-150-8
1480	Xxxxxxxxxx (XXX); 2-{(XX)-1-[(2XX)-2-(4-xxxxxxxxxxxx) xxxxxxxxxxxx]xxxxx}-3-xxxxxxx-5-(xxxxx-3-xx)xxxxxxxx-2-xx-1-xx	139001-49-3	604-105-8
1481	Xxxxxxxxxxxx (XXX); (RS)-(EZ)-2-{1-[(2E)-3-chlorallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyklohex-2-en-1-on	149979-41-9	604-715-4
1482	3,3-(Ethylendioxy)estra-5(10),9(11)-dien-17-on	5571-36-8	427-230-8
1483	Androsta-1,4,9(11)-trien-3,17-dion	15375-21-0	433-560-3
1484	Reakční xxxx: xxxxxxx-xxxxxxxxxxxxxxx (rozvětvené xxxxxx X10-X14 a X18-X30); xxxxxxx-xxxxxxxxxxxxx (xxxxxxxxxx xxxxxx C10-C14 x X18-X30); xxxxxxx-xxxxxxxxxxxxxxxxxxx (xxxxxxxxxx xxxxxx X10-X14 a X18-X30)	—	415-930-6
1485	Xxxxxxxx 1,2-benzendikarboxylová; xxxxxxx-(xxxxxx X6-X8)xxxxxx, rozvětvené, bohaté xx C7	71888-89-6	276-158-1
1486	Reakční xxxx: xxxxxxx 4,4′-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylfenolu] x xxxxxxxx 6-xxxxx-5,6-xxxxxxx-5-xxxxxxxxxxx-1-xxxxxxxxx (1:2); xxxxxxxx 4,4′-xxxxxxxxxxx[2-(2-xxxxxxx-5-xxxxxxxxxxxx)-3,6-xxxxxxxxxxxxxx] x xxxxxxxx 6-xxxxx-5,6-xxxxxxx-5-xxxxxxxxxxx-1-xxxxxxxxx (1:3)	—	427-140-9
1487	Xxxxxxxxx 1-xxxxxxx-2-(4-(4-xxxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx)-7-xxxxx-3-xxxxxxxxxxxxxxxx	150202-11-2	422-670-7
1488	Xxxxxxxx 3-xxxxxxxxxx-4-xx-17-β -xxxxxxxxxxx	302-97-6	414-990-0
1489	Xxxxxxxx (X)-2-xxxxxxxxxxx-2-[2-(xxxxxxxxxxx)xxxxxxx-4-xx]xxxxxx	64485-90-1	431-520-1
1490	Xxxxxxxxxx-xxxxxxxxxxxxxxxx	5064-31-3	225-768-6
1491	2-Xxxxxxxxxx-(2-xxxxxxxxxxxxx)	7425-14-1	231-057-1
1492	Xxxxxxxxxx-xxxxxx	84-69-5	201-553-2
1493	Xxxxxxxxxxxxxxxxxxxxxx xxxxxxxx; heptadekafluoroktan-1-sulfonová xxxxxxxx [1]	1763-23-1 [1]	217-179-8 [1]
	xxxxxx-xxxxxxxxxxxxxxxxxxxxx; kalium-heptadekafluoroktan-1-sulfonát [2]	2795-39-3 [2]	220-527-1 [2]
	xxxxxxxxxxxxx-xxxxxxxxxxxxxxxxxxxxx [3]	70225-14-8 [3]	274-460-8 [3]
	xxxxxxx-xxxxxxxxxxxxxxxxxxxxx; amonium-heptadekafluoroktansulfonát [4]	29081-56-9 [4]	249-415-0 [4]
	lithium-perfluoroktansulfonát; xxxxxxx-xxxxxxxxxxxxxxxxxxxxxxxxxxx [5]	29457-72-5 [5]	249-644-6 [5]
1494	Xxxxx-[1-(2,4-xxxxxxxxxxxx)5-(xxxxxxxxxxxxxx)-1X-1,2,4-xxxxxxx-3-xxxxxxxxxx]	103112-35-2	401-290-5
1495	1-Xxxx-2-xxxxxxxxxxxxxxxxxxxxx	158894-67-8	422-900-6
1496	1-Xxxxxxxxxxxxxxx-xxxxxxxxxxxxx	99464-83-2	444-950-8
1497	6,6′-Xxx(xxxxx-5,5′,6,6′-xxxxxxxxxx-5,5′-xxxxx)[xxxxxxxxxxx(5-(6-xxxxx-5,6-xxxxxxx-5-xxx-1-xxxxxxxxxxxxxxxxx)-6-xxxxxx-2-xxxxxxx]xx(xxxxxxxx-1-xxxxxxxx)	—	441-550-5
1498	Xxxxxxxxxxx (ISO); α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidin; 2,6-xxxxxxx-X,X-xxxxxxxx-4-(xxxxxxxxxxxxxx)xxxxxx; X,X-xxxxxxxx-2,6-xxxxxxx-4-(xxxxxxxxxxxxxx)xxxxxx	1582-09-8	216-428-8
1499	4-Xxxxx-2-xxxxxxxxxxx	1671-49-4	430-550-0
1500	Xxxxxxxxxx-4-[(4-[1-xxxxxxx-7-(4-xxxxxxxxxxxxxxxxxx)-3-xxxxxxxxx-2-xxxxxx]xxx-2,5-xxxxxxxxxxxxxx)xxx]xxxxxxx	221354-37-6	432-270-4
1501	Xxxxxxx směs: xxxxxxxxxx-6-xxxxx-3-({2,5-xxxxxxxx-4-[(3-xxxxxxxxxxxx)xxx]xxxxx}xxx)-4-xxxxxxxxxxxxxxx-2-xxxxxxxx; xxxxxxxxx-3-({4-[(7-xxxxx-1-xxxxxxx-3-xxxxx-2-xxxxxx)xxx]-2,5-xxxxxxxxxxxxx}xxx)xxxxxxx	163879-69-4	438-310-7
1502	X,X′-(xxxxxxx-4,4′-xxxx)xxxxxxxxxxx	613-35-4	210-338-2
1503	Xxxxxxxxxxxxxx	108-91-8	203-629-0
1504	Xxxxxxxxx	110-85-0	203-808-3
1505	Xxxxxxxxxxxx	7803-49-8	232-259-2
1506	Xxxxxxxxxxxxxxx-xxxxxxx; xxxxxxxxxxxx-xxxxxxxxxxxx [1]	5470-11-1 [1]	226-798-2 [1]
1506	xxx(xxxxxxxxxxxxxxx-xxxxxx); xxxxxxxxxxxx-xxxxxx (2:1) [2]	10039-54-0 [2]	233-118-8 [2]
1507	Xxxxxxxxxxxxxxxxxxx; xxxxxxxxxxxxx	—	—
1508	Xxxxxxxxxxx; 4-xxxxxx-X-xxxxx-6-(1-xxxxxxxx)-2-xxxxxxxxxxxxx	110235-47-7	600-951-7
1509	Xxxxxxxxxxxxxxx-xxxxxxxxxxxxxx; xxxxxxxxxxxx-xxxxxx (1:1) [1]	10046-00-1 [1]	233-154-4 [1]
	xxxxxxxxxxxx-xxxxxx [2]	20845-01-6 [2]	244-077-0 [2]
	hydroxylamin-dihydrogenfosfát [3]	19098-16-9 [3]	242-818-2 [3]
	hydroxylamin-4-methylbenzen-1-sulfonát [4]	53933-48-5 [4]	258-872-5 [4]
1510	(3-Xxxxx-2-xxxxxxxxxxxxx)xxxxxxxxxxxxxxxx-xxxxxxx	3327-22-8	222-048-3
1511	Xxxxxxx-3,3′,4,4′-xxxxxxxx; 3,3′-xxxxxxxxxxxxxxx	91-95-2	202-110-6
1512	Xxxxxxxxx-xxxxxxxxxxxx [1]	6094-40-2 [1]	228-042-7 [1]
	xxxxxxxxx-xxxxxxxxxxxxxx [2]	142-64-3 [2]	205-551-2 [2]
	xxxxxxxxx-xxxxxx [3]	1951-97-9 [3]	217-775-8 [3]
1513	3-(Xxxxxxxxx-1-xx)-xxxxx[x]xxxxxxxxxx-xxxxxxxxxxxx	87691-88-1	421-310-6
1514	(2-Xxxxxxxxxx)xxxxxxxx-xxxxxxxxxxxx	19398-06-2	421-460-2
1515	(2-Xxxxxxxxxx)(3-xxxxxxxxxxxxx)xxxxxxx-xxxxxxx	40722-80-3	429-740-6
1516	4-[(3-Xxxxxxxxxx)(xxxxxxxx-1-xx)xxxxxx]xxxxxx-1,2-xxxxxxxxxxxxxxxxxxxx	159939-85-2	425-030-5
1517	Xxxxx-X,X-xxxxxxxxxxxxxxxxxxx-xxxxxxx	3724-43-4	425-970-6
1518	7-Xxxxxxx-6-[3-(xxxxxxxx-4-xx)xxxxxxx]xxxxxxxxxx-4(3X)-xx;	199327-61-2	429-400-7
1519	Xxxxxxxx xxxxxx xxx(2-xxxxxxxxxxxxx) xxxxx s xxxxxxxxxxxxx (1:4)	220444-73-5	432-440-8
1520	3-Xxxxx-4-[(3-xxxxxxxxxxx)xxx]xxxxxx	202197-26-0	445-590-4
1521	Xxxxxxxxxxxxxx; 3,8-Xxxxxxx-1-xxxxx-6-xxxxxxxxxxxxxxxxxxxx-xxxxxx	1239-45-8	214-984-6
1522	(2XX)-2-xxxxx-3,3-xxxxxxxxxxxxxxxxx	144177-62-8	447-860-7
1523	9-Xxxxxxxxxxxxx-3-xxxx; (9-Ethylkarbazol-3-yl)amin	132-32-1	205-057-7
1524	(6R-trans)-1-((7-amonio-2-karboxylato-8-oxo-5-thia-1-azabicyklo-[4.2.0]okt-2-en-3-yl)methyl)pyridinium-jodid	100988-63-4	423-260-0
1525	Forchlorfenuron (XXX); 1-(2-xxxxx-4-xxxxxxx)-3-xxxxxxxxxxxxx	68157-60-8	614-346-0
1526	1,3-Xxxxxxxxxxxxxxxxxxxxxxxxxxx-2(1X)-xx; xxxxxxxxxxxxxxxxxxxxxxxx	7226-23-5	230-625-6
1527	Xxxxxxxx	91-22-5	202-051-6
1528	Xxxxxxxxxxx; 1-[4-(4-{[(2XX,4XX)-2-(2,4-xxxxxxxxxxxx)-2-(xxxxxxxx-1-xxxxxxxx)-1,3-xxxxxxxx-4-xx]xxxxxxx} xxxxx)xxxxxxxxx-1-xx]xxxxx-1-xx	65277-42-1	265-667-4
1529	Xxxxxxxxxx (XXX); (1XX,5XX;1XX,5XX)-5-(4-xxxxxxxxxxx)-2,2-xxxxxxxx-1-(1X-1,2,4-xxxxxxx-1-xxxxxxxx)xxxxxxxxxxx-1-xx	125116-23-6	603-031-3
1530	Xxxxxx-1-xxxxxx-4-{3-[1-xxxxxx-3-(xxxxxxxxxxxxxxxxx)-5-xxx-4,5-xxxxxxxxxxxxxx-4-xxxxxx]xxxx-1-xx-1-xx}-3-(xxxxxxxxxxxxxxxxx)xxxxxxx-5-xxxx	183196-57-8	418-260-2
1531	1,3,5-Xxxx(2,3-xxxxx-2-xxxxxxxxxxxx)-1,3,5-xxxxxxx-2,4,6(1X,3X,5X)-xxxxx	26157-73-3	435-010-8
1532	2,2-Xxx(xxxxxxxxxxxxx)xxxxx-1-xx-xxxx[3-(xxxxxxxx-1-xx)xxxxxxxxx]; (XXX)	52234-82-9	257-765-0
1533	4,4′-Xxxxxxxxxxxxxxx diisokyanát; xxxxxxxxxxxxx-4,4′-xxxxxxxxxxx [1]	101-68-8 [1]	202-966-0 [1]
	2,2′-xxxxxxxxxxxxxxx xxxxxxxxxxx; xxxxxxxxxxxxx-2,2′-xxxxxxxxxxx [2]	2536-05-2 [2]	219-799-4 [2]
	x-(x-xxxxxxxxxxxxxxxx)xxxxx xxxxxxxxx; xxxxxxxxxxxxx-2,4′-xxxxxxxxxxx [3]	5873-54-1 [3]	227-534-9 [3]
	xxxxxxxxxxxxxxx-xxxxxxxxxxx [4]	26447-40-5 [4]	247-714-0 [4]
1534	Cinidon ethyl (XXX); xxxxx-(X)-2-xxxxx-3-[2-xxxxx-5-(xxxxxxxx-1-xx-1,2-xxxxxxxxxxxxx)xxxxx]xxxxxxx	142891-20-1	604-318-6
1535	X-[6,9-xxxxxxx-9-[[2-xxxxxxx-1-(xxxxxxxxxxxxx)xxxxxx]xxxxxx]-6-xxx-1X-xxxxx-2-xx]xxxxxxxx	84245-12-5	424-550-1
1536	Xxxxxxxxxxxxx (XXX); (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx	149961-52-4	604-712-8
1537	2-(Xxxxxxxxxxxxx)xxxxxxxxxxxxxxxxxxxxxxxx	27366-72-9	435-470-1
1538	Xxxxxxx směs: 2,2′-[(3,3′-xxxxxxxxxxxxxx-4,4′-xxxx)xxxxxx]xxx[X-(2,4-xxxxxxxxxxxxx)-3-xxxxxxxxxxxx]; X-(2,4-xxxxxxxxxxxxx)-X′-(2-xxxxxxxxxxx)-2,2′-[(3,3′-xxxxxxxxxxxxxx-4,4′-xxxx)xxxxxx]xxx(3-xxxxxxxxxxxx); 2-[[3,3′-dichlor-4′-[[1[[(2,4-dimethylfenyl)amino]karbonyl]-2-oxopropyl]azo][1,1′-bifenyl]-4-yl]azo]-N-(2-karboxylfenyl)-3-oxo-butanamid		434-330-5
1539	Ropa, xxxx, xxxxx x xxxxx xxxx x xxxxxx xxxxxxxx xxxxxxxxxx xx xxxxxxx xxxxxxxxx x/xxxx xxxxxx xxxxx xxxxxxxxxx, xxxxx obsahují ≥ 0,1 % xxxxxxxxxxxx xxxxxxx	85536-20-5 85536-19-2 90641-12-6 90989-38-1 91995-20-9 92062-36-7 91995-61-8 101316-63-6 93821-38-6 90641-02-4 101316-62-5 90641-03-5 65996-79-4 101794-90-5 90640-87-2 84650-03-3 65996-82-9 90641-01-3 65996-87-4 90640-99-6 68391-11-7 92062-33-4 91082-52-9 68937-63-3 92062-28-7 92062-27-6 91082-53-0 91995-31-2 91995-35-6 91995-66-3 122070-79-5 122070-80-8 65996-78-3 94114-52-0 94114-53-1 94114-54-2 94114-56-4 94114-57-5 90641-11-5 8006-61-9 8030-30-6 8032-32-4 64741-41-9 64741-42-0 64741-46-4 64742-89-8 68410-05-9 68514-15-8 68606-11-1 68783-12-0 68921-08-4 101631-20-3 64741-64-6 64741-65-7 64741-66-8 64741-70-4 64741-84-0 64741-92-0 68410-71-9 68425-35-4 68527-27-5 91995-53-8 92045-49-3 92045-55-1 92045-58-4 92045-64-2 101316-67-0 64741-54-4 64741-55-5 68476-46-0 68783-09-5 91995-50-5 92045-50-6 92045-59-5 92128-94-4 101794-97-2 101896-28-0 64741-63-5 64741-68-0 68475-79-6 68476-47-1 68478-15-9 68513-03-1 68513-63-3 68514-79-4 68919-37-9 68955-35-1 85116-58-1 91995-18-5 93571-75-6 93572-29-3 93572-35-1 93572-36-2 64741-74-8 64741-83-9 67891-79-6 67891-80-9 68425-29-6 68475-70-7 68603-00-9 68603-01-0 68603-03-2 68955-29-3 92045-65-3 64742-48-9 64742-49-0 64742-73-0 68410-96-8 68410-97-9 68410-98-0 68512-78-7 85116-60-5 85116-61-6 92045-51-7 92045-52-8 92045-57-3 92045-61-9 92062-15-2 93165-55-0 93763-33-8 93763-34-9 64741-47-5 64741-48-6 64741-69-1 64741-78-2 64741-87-3 64742-15-0 64742-22-9 64742-23-0 64742-66-1 64742-83-2 64742-95-6 68131-49-7 68477-34-9 68477-50-9 68477-53-2 68477-55-4 68477-61-2 68477-89-4 68478-12-6 68478-16-0 68513-02-0 68516-20-1 68527-21-9 68527-22-0 68527-23-1 68527-26-4 68603-08-7 68606-10-0 68783-66-4 68919-39-1 68921-09-5 85116-59-2 86290-81-5 90989-42-7 91995-38-9 91995-41-4 91995-68-5 92045-53-9 92045-60-8 92045-62-0 92045-63-1 92201-97-3 93165-19-6 94114-03-1 95009-23-7 97926-43-7 98219-46-6 98219-47-7 101316-56-7 101316-66-9 101316-76-1 101795-01-1 102110-14-5 68476-50-6 68476-55-1 90989-39-2	287-502-5 287-500-4 292-636-2 292-694-9 295-281-1 295-551-9 295-323-9 309-868-8 298-725-2 292-625-2 309-867-2 292-626-8 266-013-0 309-971-8 292-609-5 283-483-2 266-016-7 292-624-7 266-021-4 292-622-6 269-929-9 295-548-2 293-766-2 273-077-3 295-543-5 295-541-4 293-767-8 295-292-1 295-295-8 295-329-1 310-170-0 310-171-6 266-012-5 302-688-0 302-689-6 302-690-1 302-692-2 302-693-8 292-635-7 232-349-1 232-443-2 232-453-7 265-041-0 265-042-6 265-046-8 265-192-2 270-077-5 271-025-4 271-727-0 272-186-3 272-931-2 309-945-6 265-066-7 265-067-2 265-068-8 265-073-5 265-086-6 265-095-5 270-088-5 270-349-3 271-267-0 295-315-5 295-430-0 295-436-3 295-440-5 295-446-8 309-871-4 265-055-7 265-056-2 270-686-6 272-185-8 295-311-3 295-431-6 295-441-0 295-794-0 309-974-4 309-987-5 265-065-1 265-070-9 270-660-4 270-687-1 270-794-3 270-993-5 271-008-1 271-058-4 272-895-8 273-271-8 285-509-8 295-279-0 297-401-8 297-458-9 297-465-7 297-466-2 265-075-6 265-085-0 267-563-4 267-565-5 270-344-6 270-658-3 271-631-9 271-632-4 271-634-5 273-266-0 295-447-3 265-150-3 265-151-9 265-178-6 270-092-7 270-093-2 270-094-8 270-988-8 285-511-9 285-512-4 295-432-1 295-433-7 295-438-4 295-443-1 295-529-9 296-942-7 297-852-0 297-853-6 265-047-3 265-048-9 265-071-4 265-079-8 265-089-2 265-115-2 265-122-0 265-123-6 265-170-2 265-187-5 265-199-0 268-618-5 270-725-7 270-735-1 270-736-7 270-738-8 270-741-4 270-771-8 270-791-7 270-795-9 270-991-4 271-138-9 271-262-3 271-263-9 271-264-4 271-266-5 271-635-0 271-726-5 272-206-0 272-896-3 272-932-8 285-510-3 289-220-8 292-698-0 295-298-4 295-302-4 295-331-2 295-434-2 295-442-6 295-444-7 295-445-2 296-028-8 296-903-4 302-639-3 305-750-5 308-261-5 308-713-1 308-714-7 309-862-5 309-870-9 309-879-8 309-976-5 310-012-0 270-690-8 270-695-5 292-695-4
1540	Xxxx, uhlí, xxxxx x xxxxx xxxx x xxxxxx deriváty xxxxxxxxxx xx xxxxxxx xxxxxxxxx a/nebo xxxxxx xxxxx zpracování, xxxxx xxxxxxxx ≥ 0,005 % xxxxxxxxxxxx benzo[a]pyrenu
		90640-85-0 92061-93-3 90640-84-9 61789-28-4 70321-79-8 122384-77-4 70321-80-1	292-606-9 295-506-3 292-605-3 263-047-8 274-565-9 310-189-4 274-566-4
1541	Ropa, xxxx, dehet x xxxxx xxxx x xxxxxx deriváty xxxxxxxxxx xx xxxxxxx xxxxxxxxx x/xxxx jiných xxxxx xxxxxxxxxx, pokud xxxxxxxx ≥ 0,1 % xxxxxxxxxxxx benzenu xxxx xxxxx xxxxxxxx ≥ 0,005 % xxxxxxxxxxxx xxxxx[x]xxxxxx
		85029-51-2 84650-04-4 84989-09-3 91995-49-2 121620-47-1 121620-48-2 90640-90-7 90641-04-6 101896-27-9 101794-91-6 91995-48-1 90641-05-7 84989-12-8 121620-46-0 90640-81-6 90640-82-7 92061-92-2 91995-15-2 91995-16-3 91995-17-4 101316-87-4 122384-78-5 84988-93-2 90640-88-3 65996-83-0 90640-89-4 90641-06-8 65996-85-2 101316-86-3 92062-22-1 96690-55-0 84989-04-8 84989-05-9 84989-06-0 84989-03-7 84989-07-1 68477-23-6 68555-24-8 91079-47-9 92062-26-5 94114-29-1 90641-00-2 68513-87-1 70321-67-4 92062-29-8 100801-63-6 100801-65-8 100801-66-9 73665-18-6 68815-21-4 65996-86-3 65996-84-1	285-076-5 283-484-8 284-898-1 295-310-8 310-166-9 310-167-4 292-612-1 292-627-3 309-985-4 309-972-3 295-309-2 292-628-9 284-901-6 310-165-3 292-603-2 292-604-8 295-505-8 295-275-9 295-276-4 295-278-5 309-889-2 310-191-5 284-881-9 292-610-0 266-017-2 292-611-6 292-629-4 266-019-3 309-888-7 295-536-7 306-251-5 284-892-9 284-893-4 284-895-5 284-891-3 284-896-0 270-713-1 271-418-0 293-435-2 295-540-9 302-662-9 292-623-1 271-020-7 274-560-1 295-544-0 309-745-9 309-748-5 309-749-0 277-567-8 272-361-4 266-020-9 266-018-8
1542	Xxxx, xxxx, xxxxx x xxxxx plyn x jejich xxxxxxxx xxxxxxxxxx xx použití xxxxxxxxx x/xxxx xxxxxx xxxxx zpracování, xxxxx xxxxxxxx ≥ 0,1 % xxxxxxxxxxxx buta-1,3-dienu
		68607-11-4 68783-06-2 68814-67-5 68814-90-4 68911-58-0 68911-59-1 68919-01-7 68919-02-8 68919-03-9 68919-04-0 68919-07-3 68919-08-4 68919-11-9 68919-12-0 68952-79-4 68952-80-7 68955-33-9 68989-88-8 92045-15-3 92045-16-4 92045-17-5 92045-18-6 92045-19-7 92045-20-0 68131-75-9 68307-98-2 68307-99-3 68308-00-9 68308-01-0 68308-10-1 68308-03-2 68308-04-3 68308-05-4 68308-06-5 68308-07-6 68308-09-8 68308-11-2 68308-12-3 68409-99-4 68475-57-0 68475-58-1 68475-59-2 68475-60-5 68476-26-6 68476-29-9 68476-40-4 68476-42-6 68476-49-3 68476-85-7 68476-86-8 68477-33-8 68477-35-0 68477-69-0 68477-70-3 68477-71-4 68477-72-5 68308-08-7	271-750-6 272-182-1 272-338-9 272-343-6 272-775-5 272-776-0 272-873-8 272-874-3 272-875-9 272-876-4 272-880-6 272-881-1 272-884-8 272-885-3 273-173-5 273-174-0 273-269-7 273-563-5 295-397-2 295-398-8 295-399-3 295-400-7 295-401-2 295-402-8 268-629-5 269-617-2 269-618-8 269-619-3 269-620-9 269-630-3 269-623-5 269-624-0 269-625-6 269-626-1 269-627-7 269-629-8 269-631-9 269-632-4 270-071-2 270-651-5 270-652-0 270-653-6 270-654-1 270-667-2 270-670-9 270-681-9 270-682-4 270-689-2 270-704-2 270-705-8 270-724-1 270-726-2 270-750-3 270-751-9 270-752-4 270-754-5 269-628-2
1543	Tris[2-chlor-1-(chlormethyl)ethyl]fosfát	13674-87-8	237-159-2
1544	Fosfid xxxxx	22398-80-7	244-959-5
1545	Xxxxxxxx-xxxxxx	25155-23-1	246-677-8
1546	Xxxxxxxxxxxxxxxxxxxx [1]	25637-99-4 [1]	247-148-4 [1]
1546	1,2,5,6,9,10-xxxxxxxxxxxxxxxxxxxx [2]	3194-55-6 [2]	221-695-9 [2]
1547	Xxxxxxxxxxxxxxx	109-99-9	203-726-8
1548	Xxxxxxxxx (směs avermektinu X1x x xxxxxxxxxxx X1x) (XXX) [1]	71751-41-2 [1]	615-339-5 [1]
1548	avermektin X1x [2]	65195-55-3 [2]	265-610-3 [2]
1549	4-Xxxx-xxxxxxxxxxxxx xxxxxxxx	98-73-7	202-696-3
1550	Xxxxxxxxxxxxxxxx xxxxx; X,X,X′,X′-xxxxxxxxxxx-4,4′-xxxxxxxxxxxxxxxxxx	129-73-7	204-961-9
1551	Xxxxxxxxxxx (XXX); 2-(2-furyl)benzimidazol	3878-19-1	223-404-0
1552	Metazachlor (XXX); 2-xxxxx-X-(2,6-xxxxxxxxxxxxx)-X-(xxxxxxx-1-xxxxxxxx)xxxxxxxx	67129-08-2	266-583-0
1553	Xx-xxxx-xxxxxxxxxxxx	110-05-4	203-733-6
1554	Xxxxxxxxxxxxxxxxxxxxx	993-16-8	213-608-8
1555	2-Xxxxxxxxxx-10-xxxxx-4-[[2-[(2-xxxxxxxxxx)xxx]-2-xxxxxxxx]xxxx]-4-xxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxx	57583-34-3	260-828-5
1556	2-Xxxxxxxxxx-(10-xxxxx-4,4-xxxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxx)	15571-58-1	239-622-4
1557	Xxxxxxxxxx (XXX); 2-[2-chlor-4-(methylsulfonyl)benzoyl]cyklohexan-1,3-dion	99105-77-8	619-394-6
1558	Bifenthrin (XXX); (2-methylbifenyl-3-yl)methyl-rel-(1R,3R)-3-[(1Z)-2-chlor-3,3,3-trifluorprop-1-en-1-yl]-2,2-dimethylcyklopropan-karboxylát	82657-04-3	617-373-6
1559	Dihexyl-ftalát	84-75-3	201-559-5
1560	Amonium-pentadekafluoroktanoát	3825-26-1	223-320-4
1561	Perfluoroktanová xxxxxxxx	335-67-1	206-397-9
1562	X-xxxxx-2-xxxxxxxxxx; 1-xxxxxxxxxxxxxxx-2-xx	2687-91-4	220-250-6
1563	Xxxxxxxxxxx (ISO); 6-xxx-2-xxxxxxx-3-xxxxxxxxxxxxxxxx-4(3X)-xx	189278-12-4	606-168-7
1564	Xxxxxxx xxxxx	1303-00-0	215-114-8
1565	Xxxxx-xxxxxx	108-05-4	203-545-4
1566	Xxxxxxxxx (XXX); 2-xxxxx-3-xxxxxx-6-xxxxxxxxxxx	74070-46-5	277-704-1
1567	2-Xxxxxxxxxx-(10-xxxxx-4,4-xxxxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxx)	57583-35-4	260-829-0
1568	Xxxxxxxxxxxxxxx-xxxxxxxxx	753-73-1	212-039-2
1569	4-Xxxxxxxxxxxxxxx	100-40-3	202-848-9
1570	Xxxxxxxxxxx (XXX); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyklohex-2-en-1-on	87820-88-0	618-075-9
1571	Cykloxydim (ISO); 2-(X-xxxxxxxxxxxxxxxxxx)-3-xxxxxxx-5-(xxxxxxxxxx-2X-xxxxxxxxx-3-xx)xxxxxxxx-2-xx-1-xx	101205-02-1	405-230-9
1572	Xxxxxxxxx (XXX); 3-chlor-N-[3-chlor-2,6-dinitro-4-(trifluormethyl)fenyl]-5-(trifluormethyl)pyridin-2-amin	79622-59-6	616-712-5
1573	Penkonazol (XXX); 1-[2-(2,4-xxxxxxxxxxxx)xxxxxx]-1X-1,2,4-xxxxxxx	66246-88-6	266-275-6
1574	Xxxxxxxxxx (XXX); xxxxx-X-[2-(4-xxxxxxxxxxxx)xxxxx]xxxxxxxx	72490-01-8	276-696-7
1575	Xxxxxx	100-42-5	202-851-5
1576	2-(Xxxxxxxxxxxxx)xxxxxxxxxxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxx	97-99-4	202-625-6
1577	Xxxxxxxxxxx	50-00-0	200-001-8
1578	Xxxxxxxxxxxxxxx	30525-89-4	608-494-5
1579	Xxxxxxxxxx, xxxxxxxxxxxxxx	463-57-0	207-339-5
1580	Xxxxxxxxx (XXX); 1-ethyl-3-[2-kyan-2-(methoxyimino)acetyl]močovina	57966-95-7	261-043-0
1581	Tributylstannan, xxxxxxxxxx	—	—
1582	Xxxxxxxxxx (XXX); 2-{2-chlor-4-(methylsulfonyl)-3-[(2,2,2-trifluorethoxy)methyl]benzoyl}cyklohexan-1,3-dion	335104-84-2	608-879-8
1583	1,2-Benzendikarboxylová xxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxx x xxxxxxxx	68515-50-4	271-093-5
1584	Xxxxxxxxxxxxx (XXX); (5x,8x)-3-(2,5-xxxxxxxxxxxxx)-8-xxxxxxx-2-xxx-1-xxxxxxxx[4,5]xxx-3-xx-4-xx-xxxxxxxxxxxxx	203313-25-1	606-523-6
1585	Xxxxxxxx-xxxxxx; 4-xxxxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx-4-xxx-xxxxxx	31717-87-0	250-778-2
1586	Xxxxxxxxxxxxxx-xxxxxx; methyl-2-([4-(dimethylamino)-6-(2,2,2-trifluorethoxy)-1,3,5-triazin-2-yl]karbamoylsulfamoyl)-3-methylbenzoát	126535-15-7	603-146-9
1587	Imazalil (XXX); 1-[2-xxxxxxxx-2-(2,4-xxxxxxxxxxxx)xxxxx]-1X-xxxxxxxx	35554-44-0	252-615-0
1588	Xxxxxxxx (XXX); 4-xxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx	1593-77-7	216-474-9
1589	Xxxxxxxx	288-32-4	206-019-2
1590	Xxxxxxx (XXX); 3-xxxxxxxxxx-6,7-xxxxxxx-1X-xxxxxxxxxx[x]xxxxxxxxx-2,4(3X,5X)-xxxx	2164-08-1	218-499-0
1591	Xxxxxxxxx (XXX); X-(2,6-xxxxxxx-3-xxxxxxxxxxx)-5,7-xxxxxxxxx[1,2,4]xxxxxxxx[1,5-x]xxxxxxxxx-2-xxxxxxxxxx	139528-85-1	604-145-6
1592	2-Xxxxxx-1-(4-xxxxxxxxxxxxxxx)-2-xxxxxxxxxxxxxxx 1-xx	71868-10-5	400-600-6
1593	2,3-Xxxxxxxxxxx-xxxxxxxxxxx	106-91-2	203-441-9
1594	Xxxxxxxxxx (XXX) 8-xxxx-xxxxx-1,4-xxxxxxxxxx[4.5]xxxxx-2-xxxxxxxx(xxxxx)(xxxxxx)xxxx	118134-30-8	601-505-4
1595	Xxxxxxxx; karbonitril	420-04-2	206-992-3
1596	Cyprokonazol (XXX); (2XX,3XX;2XX,3XX)-2-(4-xxxxxxxxxx)-3-xxxxxxxxxxx-1-(1X-1,2,4-xxxxxxx-1-xx)xxxxx-2-xx	94361-06-5	619-020-1
1597	Xxxxxxxx-xxxxxxxxx zeolit	130328-20-0	603-404-0
1598	Uhličitan xxxxxxxxx	513-78-0	208-168-9
1599	Xxxxxxxx xxxxxxxxx	21041-95-2	244-168-5
1600	Xxxxxxxx xxxxxxxxx	10325-94-7	233-710-6
1601	Xxxxxxxxxx-xxxxxxxx xxxxxxx[xxx(xxxxxxxxxxxxx)]xxxxxxx	77-58-7	201-039-8
1602	Xxxxxxxxx; 2-xxxxxx-4-xxxxxxxxxx	120-32-1	204-385-8
1603	Xxxxxxxxxxxx	84-65-1	201-549-0
1604	Xxxxxxxxxxxxxxxxxxxxx xxxxxxxx [1]	335-76-2 [1]	206-400-3[1]
	xxxxxxx-xxxxxxxxxxxxxxxxxxxxx [2]	3108-42-7 [2]	221-470-5 [2] [3]
	xxxxxx-xxxxxxxxxxxxxxxxxxxxx [3]	3830-45-3 [3]
1605	X,X′-xxxxxxxxxxxxxxxxxx; X,X′-xxxxxxxxxxxxxxxxxxx; [xxxxxxxxxxx xxxxxxxx x N,N′-methylenebismorfolinu]; [XXX] xxxxx maximální xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxxx xxx xxxxxx na xxxxx xx ve xxxxx, xxx xx xxxxxxx xx trh, ≥ 0,1 % xxxxxxxxxxxx	5625-90-1	227-062-3
1606	Xxxxxxx xxxxxxxx xxxxxxxxxxxxxxxx x 2-hydroxypropylaminem (3:2); [xxxxxxxxxxx xxxxxxxx z 3,3′-methylenbis [5–xxxxxxxxxxxxxxxxx]; [xxxxxxxxxxx uvolněný x oxazolidinu]; [MBO], xxxxx maximální xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxxx xxx xxxxxx xx xxxxx xx ve xxxxx, jak xx xxxxxxx na trh, ≥ 0,1 % xxxxxxxxxxxx	—	—
1607	Xxxxxxx xxxxxxxx xxxxxxxxxxxxxxxx x 2-hydroxypropylaminem (1:1); [xxxxxxxxxxx xxxxxxxx z α,α,α-xxxxxxxxx-1,3,5-xxxxxxx-1,3,5 (2X,4X,6X)-xxxxxxxxxxx]; [XXX], xxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxxx bez xxxxxx xx xxxxx xx xx směsi, xxx je xxxxxxx xx xxx, ≥ 0,1 % xxxxxxxxxxxx	—	—
1608	Xxxxxxxxxxxxxx	60-34-4	200-471-4
1609	Xxxxxxxxxxx (XXX); (1RS,2RS;1RS,2RS)-1-(4-chlorfenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol); α-xxxx-xxxxx-β-(4-xxxxxxxxxxxx)-1X-1,2,4-xxxxxxx-1-xxxxxxx	55219-65-3	259-537-6
1610	Xxxxxxxxxxx (XXX); (X)-3-(6-xxxxx-3-xxxxxxxxxxxxx)-1-3-xxxxxxxxxxx-2-xxxxxxxxxxxxxx; {(2X)-3-[(6-xxxxxxxxxxxx-3-xx)xxxxxx]-1,3-xxxxxxxxxxx-2-xxxxxx}xxxxxxxx	111988-49-9	601-147-9
1611	Xxxxxxxxxx (XXX); (X)-1-(xxxxxxxxxxxxxx)xxxxxxxxxxxxxxx (2X)-1-(xxxxxxxxxx)-1-xxxxxxxxx-2-xx-xxxxxxxxxxxxx	16118-49-3	240-286-6“

xxxxxxx 395 xx xxxxxxxxx xxxxx:

Xxxxxxxxxx xxxxx

Xxxxxxxxxxxx látky

Chemický xxxxx/XXX

Xxxxx XXX

Xxxxx XX

„395

Xxxxxxxx-8-xx x xxxx xxxxxx

148-24-2

134-31-6

205-711-1

205-137-1“

2)&xxxx;&xxxx;&xxxx;

Xxxxxxx XXX xx mění xxxxx:

x)	xxxxxxx 1x, 1x, 7, 13 x&xxxx;51 xx xxxxxxx;

xxxxxxx 12 xx nahrazuje xxxxx:

Xxxxxxxxxx xxxxx

Xxxxxxxxxxxx xxxxx

Xxxxxxx

Xxxxx xxxxxxxx xxxxxxx x upozornění

Chemický xxxxx/XXX

Xxxxx x xxxxxxx xxxxxx xxxxx společné xxxxxxxxxxxx

Xxxxx CAS

Číslo XX

Xxxx xxxxxxx, xxxxx xxxx

Xxxxxxxx xxxxxxxxxxx v přípravku xxxxxxxxxxx x xxxxxxx

Xxxx

„12

Xxxxxxx xxxxxx a ostatní xxxxxxxxxx xxxx směsi, xxxxx peroxid xxxxxx xxxxxxxx, xxxxxx xxxxx xxxxxxxx peroxid a xxxxxxx zinečnatý, s xxxxxxxx xxxxxx látek x xxxxxxx XX:

—	x. 1397, 1398, 1399

Xxxxxxxx xxxxxxxx

7722-84-1

231-765-0

x)	Xxxxxxxxx xx xxxxx

x)	12 % H2O2 (40 xxxxxx), xxxxxxxxxx xxxx xxxxxxxxxx

x) f) Xxxxxxxxxx xxxxxx rukavice.

a) b) x) e)

Obsahuje peroxid xxxxxx.

Xxxxxxxx xxxxx x xxxxx.

Xxx xxxxxxxx očí xxxxxxxx vypláchněte xxxxx.

x)	Xxxxxxxxx xx xxxx

x)	4 % X2X2, xxxxxxxxxx xxxx xxxxxxxxxx

x)	Xxxxxxxxx pro xxxxxxx xxxxx

x)	2 % X2X2, xxxxxxxxxx xxxx xxxxxxxxxx

x)	Xxxxxxxxx xxx ústní hygienu, xxxxxx ústní vody, xxxxx pasty a xxxxxxxxx xx xxxxxx xxxx zesvětlení xxxx

x)	≤ 0,1 % X2X2, xxxxxxxxxx xxxx xxxxxxxxxx

x)	Xxxxxxxxx xx xxxxxx xxxx xxxxxxxxxx xxxx

x)	&xx; 0,1 % ≤ 6 % H2O2, xxxxxxxxxx xxxx uvolněného

K prodeji xxxxx xxxxxx lékařům. X každého xxxxx xxxxxxx musí být xxxxx použití provedeno xxxxxx lékařem xx xxxxxx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Rady 2005/36/XX&xxxx;(*1) nebo xxx xxxx xxxxxx dohledem, xxxxx xx zaručena xxxxxxxxxx xxxxxx xxxxxxxxxxx.

Xxxx xxxxxx spotřebiteli k xxxxxxxxx xxxxx použití.

Nepoužívat x xxxx xxxxxxxx 18 xxx.

Xxxxxxxxxxx X2X2 xxxxxxxxxx xxxx xxxxxxxxxx xxxxxxx x xxxxxxxxxx.

Xxxxxxxxxx x xxxx xxxxxxxx 18 xxx.

X xxxxxxx xxxxx xxxxxx lékařům. X xxxxxxx xxxxx xxxxxxx musí xxx xxxxx použití xxxxxxxxx xxxxx xxxxxx lékařem xxxx xxx xxxx xxxxxx xxxxxxxx, pokud xx xxxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxxxx.

Xxxx xxxxxx xxxxxxxxxxxx x xxxxxxxxx xxxxx xxxxxxx.

x)	Xxxxxxxxx určené xxx xxxx

x)	2 % X2X2, xxxxxxxxxx nebo xxxxxxxxxx

x)	Xxx xxx profesionální xxxxxxx.

Xx etiketě xx xxxxx:

„Xxx pro xxxxxxxxxxxxx xxxxxxx.

Xxxxxxxx xxxxx s xxxxx.

Xxx zasažení xxx xxxxxxxx xxxxxxxxxxx vodou.

Obsahuje xxxxxxx xxxxxx.“

xxxxxxxx xx xxxx položky, xxxxx xxxxx:

Xxxxxxxxxx xxxxx	Xxxxxxxxxxxx látky				Omezení			Znění xxxxxxxx použití x xxxxxxxxxx
Xxxxxxxxxx xxxxx	Xxxxxxxx xxxxx/ XXX	Xxxxx x xxxxxxx xxxxxx xxxxx xxxxxxxx xxxxxxxxxxxx	Xxxxx CAS	Číslo XX	Xxxx xxxxxxx, xxxxx xxxx	Xxxxxxxx xxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxx x xxxxxxx	Xxxx
x	x	x	x	x	x	x	x	x
„311	Xxxxxxx(2,4,6-xxxxxxxxxxxxxxx)xxxxxx xxxx	Xxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxx	75980-60-8	278-355-8	Xxxxxxx xxxxxxx xxxxx	5,0 %	Xxxxxxxxxxxxx xxxxxxx	Xxx xxx xxxxxxxxxxxxx použití. Zabraňte xxxxx x kůží. Čtěte pečlivě xxxxx x použití.
312	2-Furaldehyd	Furfural	98-01-1	202-627-7		0,001 %“

3)&xxxx;&xxxx;&xxxx;

Xxxxxxx V se xxxx xxxxx:

x&xxxx;xxxxx xx xxx 2 xxxxxxxxx tímto:

„2.	Veškeré xxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxxxxxx x&xxxx;xxxx xxxxxxx, x&xxxx;xxxxx xx xxxxxxxx formaldehyd, musí xxx xxxxxxxx xxxxxxxxxxx „xxxxxxxx xxxxxxxxxxx“, xxxxxxxx xxxxxxxxxxx xxxxxxxxxxxx v konečném xxxxxxx xxxxxxxx 0,05 %.“;

b)	položky 5, 31, 40 x&xxxx;41 se xxxxxxx;

xxxxxxx 28 xx xxxxxxxxx xxxxx:

Xxxxxxxxxx xxxxx	Xxxxxxxxxxxx xxxxx				Xxxxxxxx			Xxxxx xxxxxxxx použití x xxxxxxxxxx
Xxxxxxxxxx xxxxx	Xxxxxxxx název/INN	Název x xxxxxxx xxxxxx xxxxx xxxxxxxx xxxxxxxxxxxx	Xxxxx XXX	Xxxxx XX	Xxxx výrobku, xxxxx xxxx	Xxxxxxxx koncentrace x xxxxxxxxx xxxxxxxxxxx k xxxxxxx	Xxxx
x	x	x	x	x	x	x	x	x
„28	Xxxxxxxxxxxxxxxx-xxxxxxxx-xxxxxxxxxxxx	Xxxxxxxxxxxxxxx xxxxxxxxx	32289-58-0, 27083-27-8, 28757-47-3, 133029-32-0	608-723-9 608-042-7		0,1 %	Xxxxxxxxxx x aplikacích, xxx xxxxx xxxx x xxxxxxxx plic xxxxxxxxx xxxxxxxxx xxx vdechování.“

(*1) Směrnice Xxxxxxxxxx xxxxxxxxxx x Xxxx 2005/36/ES xx xxx 7. xxxx 2005 x xxxxxxxx xxxxxxxxx xxxxxxxxxxx (Xx. xxxx. L 255, 30.9.2005, x.&xxxx;22).“

Plné znění - 32019R0831

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Plné znění - 32019R0831

Na co čekáte? Nečekejte už ani minutu. Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.